MOBILE VIEW  | 

ISOPROPYL ALCOHOL

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Isopropyl alcohol is an antiseptic with bactericidal properties.

Specific Substances

    A) No Synonyms were found in group or single elements
    1.2.1) MOLECULAR FORMULA
    1) C3H8O

Available Forms Sources

    A) FORMS
    1) Isopropanol is a colorless, flammable liquid with a pleasant odor resembling rubbing alcohol and a slightly bitter taste (ACGIH, 2001; Ashford, 2001; Lewis, 2001; Lewis, 2000)
    B) SOURCES
    1) NOTE: Not all rubbing alcohol contains isopropanol; some rubbing alcohol contains ethanol.
    2) Isopropanol is produced from the indirect hydration of propylene and from the treatment of propylene with sulfuric acid (strong acid method). It may also be recovered from aqueous mixtures by salting out with sodium chloride, sodium sulfate, sodium hydroxide, etc (Ashford, 2001; Budavari, 1996; Lewis, 2001).
    3) Isopropyl alcohol may form in the postmortem state (Davis et al, 1984). This is presumably the result of bacterial or other putrification processes.
    C) USES
    1) Isopropanol is a raw material used for the synthesis of acetone, glycerin, and other chemicals; it is also used as a solvent for oils, gums, creosote, and resins, and as a deicing agent for liquid fuels. A 70% solution of isopropanol in water is widely used as rubbing alcohol. It is also found in skin lotions, hair care and shaving products, some home aerosols, and pharmaceuticals (ACGIH, 2001; Ashford, 2001; Budavari, 1996; Hathaway et al, 1996; Lewis, 2001) .
    a) NOTE: Not all rubbing alcohol contains isopropanol; some rubbing alcohol contains ethanol.
    2) Isopropanol is also used in perfumes, soaps, and window cleaners (AAR, 2000). It is used in foods as a synthetic flavoring adjuvant and in nonalcoholic beverages, candy, and baked goods (HSDB, 2003).
    3) Isopropanol is used for medicinal purposes as an antiseptic, disinfectant, in various liniments, tinctures, and tonics, and as a bathing solution for surgical sutures and dressings (HSDB, 2003).
    4) Isopropanol may be found in the following products: Frost remover (25% to 100%); liquid detergent (0% to 12%); disinfectant cleaners (6% to 15%); glass window cleaner (0% to 25%); jewelry cleaner (10% to 15%); rubbing alcohol (70%); stain spot remover (10% to 30%) (Zaman et al, 2002a).
    5) FOLK MEDICINE: Isopropyl alcohol toxicity developed in a 4-year-old girl who was bathed in a preparation of chamomile and isopropyl alcohol during a Mexican folk healing ritual (curanderismo, to treat evil spirits) (DeBellonia et al, 2008).

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) USES: Primarily used as a topical antiseptic. Typical household preparations contain 70% isopropanol. Also used as a solvent in many household, cosmetic, and topical pharmaceutical products. Isopropanol baths are occasionally used in some cultural practices to relieve fevers.
    B) TOXICOLOGY: CNS depressant and gastrointestinal (GI) irritant; acetone (metabolite) likely contributes to CNS depression.
    C) EPIDEMIOLOGY: Isopropyl alcohol exposure is the most common toxic alcohol exposure reported to poison centers in the United States. Cases occur in the thousands per year, but toxicity is rarely severe.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE TOXICITY: May include CNS depression, dysarthria, ataxia, nystagmus, similar to ethanol intoxication, nausea/vomiting, flushing, headache, tachycardia, mild hyperglycemia, ketonuria, and ketonemia WITHOUT metabolic acidosis. Although isopropyl alcohol is metabolized to acetone and does not usually cause metabolic acidosis, metabolic acidosis can occur in patients who drink isopropyl alcohol, experience decreased caloric intake, and develop alcoholic ketoacidosis.
    2) SEVERE TOXICITY: May include hemorrhagic gastritis, hypotension, respiratory depression, and coma. Death is rare and likely secondary to respiratory depression and aspiration.
    3) EYE EXPOSURE: Splash or vapor exposure can cause irritation, burns, corneal abrasion and ulceration.
    4) DERMAL EXPOSURE: Repeated dermal application can cause systemic toxicity (primarily CNS depression), especially in infants and young children, because of more extensive dermal absorption and greater surface area-to-volume ratios.
    5) PARENTERAL EXPOSURE: CNS and respiratory depression are possible; hemolysis has developed in 1 patient.
    0.2.20) REPRODUCTIVE
    A) At the time of this review, no reproductive studies were found for isopropanol in humans.
    0.2.21) CARCINOGENICITY
    A) Isopropanol is not regarded as a human carcinogen at the present time.
    B) Some studies reported an increased incidence of paranasal, laryngeal, and pharynx cancers, but this was felt to be related to other chemicals used in the manufacture of isopropanol using the strong acid method.

Laboratory Monitoring

    A) Monitor vital signs and mental status.
    B) Obtain a metabolic panel, serum isopropyl alcohol and acetone concentrations. Ketonemia and ketonuria may present within 1 to 3 hours of ingestion, but acidosis is NOT expected. Isopropanol elevates measured serum osmolality.
    C) Monitor for evidence of hemorrhagic gastritis (hemoccult stools, gastroccult emesis, hematocrit).

Treatment Overview

    0.4.2) ORAL/PARENTERAL EXPOSURE
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) Treatment is symptomatic and supportive care.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Treatment is symptomatic and supportive care. Critically ill patients will need emergent management of airway, breathing, and circulation. CNS depression may require intubation, and alcohol-induced vasodilation and vomiting may lead to hypotension requiring fluid resuscitation, and rarely vasopressors.
    C) DECONTAMINATION
    1) PREHOSPITAL: Do not administer prehospital activated charcoal, because of limited utility and the risk of aspiration if CNS depression develops. Irrigate exposed eyes with water. Wash exposed skin with soap and water and remove contaminated clothing.
    2) HOSPITAL: Activated charcoal and gastric lavage are not indicated. Consider simple nasogastric tube aspiration for large, recent ingestions if the airway is protected.
    D) AIRWAY MANAGEMENT
    1) May be necessary after large ingestions if the patient’s mental status is so depressed they cannot protect their airway.
    E) ANTIDOTE
    1) No specific antidote is available.
    F) ENHANCED ELIMINATION
    1) Hemodialysis could be considered in extreme cases; however, most patients should improve with supportive care. Dialysis should be considered when levels are extremely high (eg, greater than 500 to 600 mg/dL) or if hypotension does not respond to fluids and vasopressors.
    G) PATIENT DISPOSITION
    1) HOME CRITERIA: Asymptomatic children (other than mild drowsiness) with an acute inadvertent ingestion may be monitored at home. Children younger than 6 years old who have ingested 30 mL or greater are more likely to become symptomatic and should be referred for evaluation and treatment.
    2) OBSERVATION CRITERIA: Patients with deliberate ingestions or any patient who manifests symptoms should be sent to a health care facility for observation until symptoms resolve.
    3) ADMISSION CRITERIA: Patients with significant persistent CNS toxicity (somnolence, intoxication, coma), hypotension or severe hemorrhagic gastritis should be admitted to an intensive care setting.
    4) CONSULT CRITERIA: Consult the poison center or medical toxicologist for assistance in managing patients with severe toxicity (eg, coma) or in whom the diagnosis is not clear.
    H) PITFALLS
    1) Missing an ingestion of another toxic alcohol (eg, ethylene glycol, methanol) or other possible etiologies for a patient’s symptoms. In cases of hemorrhagic gastritis, it is imperative the patient’s hemoglobin is stable.
    I) PHARMACOKINETICS
    1) Isopropanol is well absorbed by the body and quickly distributes into body fluids (volume of distribution 0.6 L/kg). It is metabolized by alcohol dehydrogenase to acetone (half-life of 2.5 to 3 hours).
    J) DIFFERENTIAL DIAGNOSIS
    1) CNS DEPRESSION: Other toxic alcohols, benzodiazepines, opiates/opiods, antipsychotic medications
    2) KETOSIS: Ethanol (alcoholic ketoacidosis), diabetic ketoacidosis, starvation ketosis.
    a) Chronic ethanol abusers may present with alcoholic ketoacidosis after a sudden reduction of caloric intake. Patients with alcoholic ketoacidosis and isopropyl alcohol intoxication may be misdiagnosed with ethanol, methanol, or ethylene glycol intoxication.
    3) GASTRITIS: Nonsteroidal anti-inflammatories, heavy metals
    0.4.3) INHALATION EXPOSURE
    A) Supportive care.
    0.4.4) EYE EXPOSURE
    A) Irrigate with water or normal saline, slit lamp examination if irritation persists.
    0.4.5) DERMAL EXPOSURE
    A) OVERVIEW
    1) Wash exposed skin with soap and water and remove contaminated clothing. Supportive care.
    0.4.6) PARENTERAL EXPOSURE
    A) Intubation and ventilation may be needed. Treat hypotension with fluids, vasopressors if needed. Monitor hematocrit and urinalysis for evidence of hemolysis. Monitor for local tissue injury/phlebitis at the site of injection.

Range Of Toxicity

    A) Toxic oral dose is about 0.5 to 1 mL/kg of rubbing alcohol (70% isopropyl alcohol) but varies depending on the individual patient and coingestants.
    B) Alcohol naive patients may be far more symptomatic at lower levels. Fatalities have occurred in adults with ingestion of as little as 240 mL, but patients ingesting up to 1 L have recovered with supportive care. There have been reports of toxicity in both children and adults after dermal exposure for fever, which is likely a combination of both skin absorption and inhalation.

Summary Of Exposure

    A) USES: Primarily used as a topical antiseptic. Typical household preparations contain 70% isopropanol. Also used as a solvent in many household, cosmetic, and topical pharmaceutical products. Isopropanol baths are occasionally used in some cultural practices to relieve fevers.
    B) TOXICOLOGY: CNS depressant and gastrointestinal (GI) irritant; acetone (metabolite) likely contributes to CNS depression.
    C) EPIDEMIOLOGY: Isopropyl alcohol exposure is the most common toxic alcohol exposure reported to poison centers in the United States. Cases occur in the thousands per year, but toxicity is rarely severe.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE TOXICITY: May include CNS depression, dysarthria, ataxia, nystagmus, similar to ethanol intoxication, nausea/vomiting, flushing, headache, tachycardia, mild hyperglycemia, ketonuria, and ketonemia WITHOUT metabolic acidosis. Although isopropyl alcohol is metabolized to acetone and does not usually cause metabolic acidosis, metabolic acidosis can occur in patients who drink isopropyl alcohol, experience decreased caloric intake, and develop alcoholic ketoacidosis.
    2) SEVERE TOXICITY: May include hemorrhagic gastritis, hypotension, respiratory depression, and coma. Death is rare and likely secondary to respiratory depression and aspiration.
    3) EYE EXPOSURE: Splash or vapor exposure can cause irritation, burns, corneal abrasion and ulceration.
    4) DERMAL EXPOSURE: Repeated dermal application can cause systemic toxicity (primarily CNS depression), especially in infants and young children, because of more extensive dermal absorption and greater surface area-to-volume ratios.
    5) PARENTERAL EXPOSURE: CNS and respiratory depression are possible; hemolysis has developed in 1 patient.

Vital Signs

    3.3.3) TEMPERATURE
    A) HYPOTHERMIA may occur due to CNS depression and vasodilation (Natowicz et al, 1985; Adelson, 1962; Visudhiphan & Kaufman, 1971).
    3.3.4) BLOOD PRESSURE
    A) HYPOTENSION: Ingestion, dermal absorption, or inhalation of large quantities may cause hypotension (Pappas et al, 1991; Lewis, 2000a; Vivier et al, 1994).
    B) Hypotension and coma are the strongest predictors of mortality (Zaman et al, 2002).
    3.3.5) PULSE
    A) TACHYCARDIA is common (Kelner & Bailey, 1983).
    B) BRADYCARDIA: Ingestion or inhalation of large quantities of vapor may cause a decrease in pulse rate (Lewis, 2000a; Vicas & Beck, 1993).

Heent

    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) IRRITATION: Exposure to isopropyl alcohol vapors can cause irritation. Mild irritation may develop following exposure to isopropyl vapor at 400 ppm. Severe irritation may develop following direct contact to isopropyl alcohol liquid (IPCS INCHEM, 1990).
    a) Subjects exposed to isopropyl alcohol vapors developed a sense of irritation at 800 ppm. Brief splash contact to human eyes has resulted in transient burning, stinging, and tearing (Grant & Schuman, 1993).
    2) CORNEAL ABRASION: Corneal abrasion may occur following direct contact to isopropyl alcohol liquid (IPCS INCHEM, 1990).
    a) CASE REPORT: A 2.5-year-old boy with fever developed eye irritation and pain due to a splash injury after his parents used isopropanol sponge-bathing as a home remedy to reduce his fever. The examination of the eyes revealed a large left corneal abrasion. His corneal abrasion resolved after symptomatic treatment, including antibiotic ointment and patching for 5 days (Osborn & Rosales, 1981a).
    3) CORNEAL ULCERATION: Two patients developed corneal ulceration after inadvertently applying ear drops, containing acetic acid and isopropyl alcohol, into their eyes (Brown, 2013).
    4) CORNEAL EPITHELIUM CHANGES: Patchy epithelial loss with rapid recovery has been reported after prolonged eye contact with the vapor (Osborn & Rosales, 1981).
    5) CORNEAL BURNS: If splashed in the eye, it can cause corneal burns (Sax, 1984).
    6) PUPILS may be dilated or sluggishly reactive to light (Mydler et al, 1993; Vivier et al, 1994)
    7) NYSTAGMUS may occur (Mydler et al, 1993).
    B) ANIMAL STUDIES
    1) IRITIS: In rabbit eyes, 0.1 mL of a 70% solution caused conjunctivitis and corneal opacity (ACGIH, 2001).
    2) Moderate eye effects have been observed in rabbits with exposure to isopropyl alcohol 10 mg (Lewis, 2000a) and with eye irrigation for 3 minutes with 50% isopropyl alcohol (Grant & Schuman, 1993).
    3.4.4) EARS
    A) WITH POISONING/EXPOSURE
    1) Human ear injury due to isopropyl alcohol has not been reported.
    B) ANIMAL STUDIES
    1) In guinea pigs, inhalation of 400 ppm for 24 hours resulted in middle ear mucosal cells. At 5500 ppm, severe damage occurred and recovery did not occur at 2 weeks after exposure (Ohashi et al, 1987).
    3.4.5) NOSE
    A) WITH POISONING/EXPOSURE
    1) IRRITATION: Concentrations of 400 ppm produce mild local irritation of the nose and upper respiratory tract (Lewis, 2000a)
    B) ANIMAL STUDIES
    1) Similar reversible changes are seen in guinea pig nasal mucosa at 400 and 5500 ppm when inhaled for 24 hours (Ohashi et al, 1988a; Ohashi et al, 1988b). At 5500 ppm for the same duration, severe pathological degeneration of the respiratory mucosa occurred (ACGIH, 2001).

Cardiovascular

    3.5.2) CLINICAL EFFECTS
    A) HYPOTENSIVE EPISODE
    1) WITH POISONING/EXPOSURE
    a) Hypotension occurs in severe poisonings and may result from peripheral vasodilation (DeBellonia et al, 2008; Emadi & Coberly, 2007; Natowicz et al, 1985; Visudhiphan & Kaufman, 1971; Vivier et al, 1994; King et al, 1970; Pappas et al, 1991).
    b) CASE REPORT: A 37-year-old man developed deep coma (Glasgow coma scale 6) and hypotension (BP 77/40 mmHg) after drinking 200 to 250 mL of a "fat solvent for engines" containing 100% isopropanol. On admission, his isopropanol blood level was 5 g/L. His condition did not improve following flumazenil and naloxone therapy. However, he was treated successfully with a 4-hour hemodialysis (Trullas et al, 2004).
    B) TACHYARRHYTHMIA
    1) WITH POISONING/EXPOSURE
    a) Tachycardia is common (DeBellonia et al, 2008; Kelner & Bailey, 1983).
    C) CARDIAC ARREST
    1) Bradycardic cardiac arrest developed 11.5 hours postexposure in a neonate following inhalational exposure to 70% isopropyl alcohol for approximately 2 hours (Vicas & Beck, 1993). Isopropyl alcohol and acetone levels were measured in the serum and urine. The child had multiple dysmorphic features and had just undergone surgery for gastroschisis.
    D) CHEST PAIN
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 45-year-old female chronic ethanol abuser, presented with confusion, agitation, and chest pain after drinking a large amount of alcohol during the previous 2 weeks. Laboratory results revealed a wide plasma osmolal gap (44 mmol/kg) and anion gap metabolic acidosis (15 mmol/L) with elevated serum beta-hydroxybutyric acid levels (3620 mcmol/L), normal serum lactate levels, negligible levels of salicylate and ethanol, and elevated acetone concentration (at least 80 mg/L). Because of a suspicion of ethanol or ethylene glycol intoxication, she was treated with a loading dose of 15 mg/kg of fomepizole; however, she remained confused. Further laboratory analysis revealed elevated isopropyl alcohol concentrations (1.69 mmol/L) and acetone (38 mmol/L). At this time, she admitted to drinking rubbing alcohol and eating little food for several days. Following the discontinuation of fomepizole and continued supportive therapy, including treatment for alcohol withdrawal symptoms, her condition gradually improved and returned to baseline mental and functional status after 3 days (Meng et al, 2015).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) RESPIRATORY FAILURE
    1) WITH POISONING/EXPOSURE
    a) In patients with severe intoxication, respiratory depression or failure may occur (Vujasinovic et al, 2007; Adelson, 1962; Pappas et al, 1991; Lewis, 2000a; Visudhiphan & Kaufman, 1971; Manring et al, 1997). Death from respiratory paralysis may occur in 24 to 36 hours following ingestion (Proctor et al, 1989).
    b) CASE REPORT: Respiratory depression and coma occurred rapidly following an accidental intravenous infusion of 35% isopropyl alcohol (800 mL) in saline in a 19-year-old previously healthy man. Mechanical ventilation was required. Serum isopropyl alcohol level was 142 mg/dL 5 hours after infusion and acetone level was 117 mg/dL. The patient's recovery was uneventful following hemodialysis (Manring et al, 1997).
    B) BRONCHITIS
    1) WITH POISONING/EXPOSURE
    a) Hemorrhagic tracheobronchitis may be present (Goldfrank, 2002).
    C) FIBROSIS OF LUNG
    1) WITH POISONING/EXPOSURE
    a) CHRONIC INHALATION: A 63-year-old woman presented with bilateral lung infiltrates, hemoptysis, and acute respiratory failure after chronically abusing isopropyl alcohol by inhalation multiple times daily for 3 years. On presentation, her oxygen saturation was 88% on room air, blood pressure was 121/72 mmHg, heart rate was 88 beats/min, and temperature was 98 degrees F. An echocardiogram revealed a left ventricular ejection fraction of more than 70%, no valvular or wall motion abnormalities, and a small pericardial effusion. A video-assisted thoracotomy (VATS) showed significant and diffuse pleural adhesions involving the entire pleural cavity with the entire lung adhered to the pleural wall. Bronchoscopy revealed unremarkable mucosa with some bloody secretions throughout the subsegmental bronchi. A lung biopsy showed an airway centric pattern of fibrosis and chronic inflammation with scattered lymphoid aggregates. Following aggressive supportive care, including steroids, antibiotics, and albuterol therapies, her symptoms gradually improved. On follow-up, 5 months later, computed tomography of the chest revealed significant improvement in lung infiltrates and ground glass opacities with the presence of residual subpleural ground glass opacities (Blow et al, 2012).
    D) DISORDER OF RESPIRATORY SYSTEM
    1) WITH POISONING/EXPOSURE
    a) PREEXISTING RESPIRATORY CONDITIONS: In persons with impaired pulmonary function, especially those with obstructive airway diseases, inhalation of isopropanol might cause exacerbation of symptoms, due to its irritant properties (HSDB, 2003).

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) CENTRAL NERVOUS SYSTEM DEFICIT
    1) WITH POISONING/EXPOSURE
    a) The stimulatory phase seen with ethyl alcohol is generally absent following isopropyl alcohol ingestion, which may result in apparent inebriation, headache, weakness, hypothermia, lethargy, sleepiness, hypotonia, and coma. Deep coma and areflexia are common following severe intoxication (Vujasinovic et al, 2007).
    b) Infants and adults have developed hypotonia and coma following prolonged topical application of isopropyl alcohol for fever relief (McFadden & Haddow, 1969; Senz & Goldfarb, 1958; Garrison, 1953; Martinez et al, 1986; Visudhiphan & Kaufman, 1971) Vivier et al, 1991).
    c) Lethargy or unresponsiveness was reported in 20% of 35 pediatric patients who had ingested isopropyl alcohol accidentally. The patients recovered without sequelae (Stephan et al, 1997).
    d) CASE REPORT: A 43-year-old man with alcoholism became hypotensive and delirious after drinking an unknown amount of a hand sanitizer containing isopropanol (63% v/v). His isopropanol and acetone levels were 13.6 mg/dL and 269.4 mg/dL (normal range, 0 to 1.9 for both), respectively. Following supportive therapy, he recovered completely (Emadi & Coberly, 2007).
    e) Somnolence and coma have been reported following acute isopropanol intoxication (Vujasinovic et al, 2007).
    f) CASE REPORT: A 45-year-old female chronic ethanol abuser, presented with confusion, agitation, and chest pain after drinking a large amount of alcohol during the previous 2 weeks. Laboratory results revealed a wide plasma osmolal gap (44 mmol/kg) and anion gap metabolic acidosis (15 mmol/L) with elevated serum beta-hydroxybutyric acid levels (3620 mcmol/L), normal serum lactate levels, negligible levels of salicylate and ethanol, and elevated acetone concentration (at least 80 mg/L). Because of a suspicion of ethanol or ethylene glycol intoxication, she was treated with a loading dose of 15 mg/kg of fomepizole; however she remained confused. Further laboratory analysis revealed elevated isopropyl alcohol concentrations (1.69 mmol/L) and acetone (38 mmol/L). At this time, she admitted to drinking rubbing alcohol and eating little food for several days. Following the discontinuation of fomepizole and continued supportive therapy, including treatment for alcohol withdrawal symptoms, her condition gradually improved and returned to baseline mental and functional status after 3 days (Meng et al, 2015).
    B) ERYTHROMELALGIA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 38-year-old woman developed an acute sensori-motor axonal polyneuropathy (confirmed by nerve conduction studies) and erythromelalgia after walking barefooted for several hours on carpets soaked by a disinfectant containing isopropanol (Microban(R)). She experienced burning paresthesia in both feet and legs temporarily relieved by immersion in cold water. Neurological examination showed dysesthesia to light touch from the knees down and distal hyperesthesia to pin prick. In addition, vibration sense and proprioception were impaired distally, and symmetrical exclusively distal weakness was present. Although high-dose oral corticosteroid therapy was not effective, amitriptyline and gabapentin partially relieved her symptoms (Rajabally & Mortimer, 2004).
    C) CEREBELLAR DISORDER
    1) WITH POISONING/EXPOSURE
    a) Ataxia, dysarthria, and nystagmus are reported less commonly than with ethanol exposure (Kelner & Bailey, 1983; Rich et al, 1990).
    b) Wernicke's encephalopathy should be considered in patients with the above symptoms (Wrenn, 1991).
    c) Ataxia and combativeness occurred in 20% of 35 pediatric patients who accidentally ingested isopropyl alcohol (Stephan et al, 1997).
    D) HYPOREFLEXIA
    1) WITH POISONING/EXPOSURE
    a) Hyporeflexia and areflexia usually accompany significant CNS depression (Kelner & Bailey, 1983; Pappas et al, 1991; Mydler et al, 1993).
    E) CEREBROSPINAL FLUID: PROTEIN - INCREASED +
    1) WITH POISONING/EXPOSURE
    a) RARE EFFECT: CSF PROTEIN: Marked elevation in CSF protein (peak 200 mg/mL) was reported in a 2-year-old child with a serum isopropanol level of 520 mg/dL (Visudhiphan & Kaufman, 1971).
    F) SEIZURE
    1) WITH POISONING/EXPOSURE
    a) RARE EFFECT: Seizures were reported in a 21-day-old infant after the child's mother repeatedly applied cotton soaked with 70% isopropyl alcohol to the umbilicus with every diaper change for 3 weeks (Vivier et al, 1994).
    b) CASE REPORT: A 4-year-old girl became unresponsive and developed generalized tonic-clonic motor seizures (lasting 2 to 3 minutes) approximately 3 hours after bathing in a preparation of chamomile and isopropyl alcohol during a Mexican folk healing ritual (curanderismo, to treat evil spirits). Following supportive therapy, she recovered over the next 2 days (DeBellonia et al, 2008).
    G) COMA
    1) WITH POISONING/EXPOSURE
    a) Somnolence and coma have been reported following acute isopropanol intoxication (DeBellonia et al, 2008; Vujasinovic et al, 2007).
    b) Coma and respiratory depression occurred rapidly following an accidental intravenous infusion of 35% isopropyl alcohol (800 mL) in saline in a 19-year-old, previously healthy man. The patient was awake and alert and extubated following hemodialysis; recovery was uneventful (Manring et al, 1997).
    c) CASE REPORT: A 37-year-old man developed deep coma (Glasgow coma scale 6) and hypotension (BP 77/40 mmHg) after drinking 200 to 250 mL of a "fat solvent for engines" containing 100% isopropanol. On admission, his isopropanol blood level was 5 g/L. His condition did not improve following flumazenil and naloxone therapy. However, he was treated successfully with a 4-hour hemodialysis (Trullas et al, 2004).
    d) CASE REPORT: After ingesting rubbing alcohol, a 38-year-old man with a history of paranoid schizophrenia and suicide attempts developed coma and the presence of skew eye deviation (left eye lower than right) mimicking basilar artery thrombosis. Motor examination revealed flaccid tetraplegia with no response to noxious stimuli. Deep tendon reflexes were hypoactive in the upper and absent in the lower extremities without response to plantar stimulation. Brain CT angiography revealed a patent basilar artery. Gas chromatography revealed an isopropanol level of 287 mg/dL with an acetone level of 123 mg/dL. Following supportive therapy, he recovered over the next 48 hours (Mueller-Kronast et al, 2003).
    H) PSYCHOMOTOR AGITATION
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 45-year-old female chronic ethanol abuser, presented with confusion, agitation, and chest pain after drinking a large amount of alcohol during the previous 2 weeks. Laboratory results revealed a wide plasma osmolal gap (44 mmol/kg) and anion gap metabolic acidosis (15 mmol/L) with elevated serum beta-hydroxybutyric acid levels (3620 mcmol/L), normal serum lactate levels, negligible levels of salicylate and ethanol, and elevated acetone concentration (at least 80 mg/L). Because of a suspicion of ethanol or ethylene glycol intoxication, she was treated with a loading dose of 15 mg/kg of fomepizole; however, she remained confused. Further laboratory analysis revealed elevated isopropyl alcohol concentrations (1.69 mmol/L) and acetone (38 mmol/L). At this time, she admitted to drinking rubbing alcohol and eating little food for several days. Following the discontinuation of fomepizole and continued supportive therapy, including treatment for alcohol withdrawal symptoms, her condition gradually improved and returned to baseline mental and functional status after 3 days (Meng et al, 2015).

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) VOMITING
    1) WITH POISONING/EXPOSURE
    a) Patients often vomit following isopropyl alcohol ingestion (Stremski & Hennes, 2000).
    B) GASTROINTESTINAL HEMORRHAGE
    1) WITH POISONING/EXPOSURE
    a) GI hemorrhage and hematemesis have been reported (Lehman & Chase, 1944; Zaman et al, 2002).
    b) CASE REPORT: A 2-year-old boy developed hemorrhagic gastritis after topical isopropanol exposure. His grandmother used isopropanol (half of a 240 mL bottle of isopropanol 70%) sponge-bathing as a home remedy to reduce his fever. Following supportive therapy, he recovered without further sequelae. Laboratory results were serum isopropanol 92 mg/dL (normal 0), acetone 181 mg/dL (normal 0), and serum osmolality 341 mOsm/kg (osmolal gap 55 mOsm/L) (Dyer et al, 2002).
    C) ABDOMINAL PAIN
    1) WITH POISONING/EXPOSURE
    a) Abdominal pain and cramping, along with gastritis, nausea, and vomiting have been reported (Zaman et al, 2002).
    D) TOXIC EFFECT OF ISOPROPYL ALCOHOL
    1) WITH THERAPEUTIC USE
    a) RECTAL ABSORPTION
    1) RECTAL ADMINISTRATION: Systemic toxicity has developed after rectal administration; serum and urinary isopropyl alcohol levels are comparable to those found after ingestion (Corbett & Meier, 1968; Barnett et al, 1990).

Hepatic

    3.9.2) CLINICAL EFFECTS
    A) LIVER DAMAGE
    1) WITH POISONING/EXPOSURE
    a) Mild hepatic injury has been reported (Chapin, 1949).
    b) Isopropyl alcohol appears to greatly accentuate the hepatic injury caused by carbon tetrachloride.
    B) INJURY OF LIVER
    1) WITH POISONING/EXPOSURE
    a) INTERACTION
    1) Multiple cases of hepatic toxicity, some with associated renal injury and pulmonary edema, have occurred when carbon tetrachloride (CC14) was transiently used in manufacturing facilities where isopropyl alcohol exposure was ongoing (Deng et al, 1987) Polland et al, 1976). Acute oral isopropyl alcohol exposure enhances carbon tetrachloride toxicity in the rat (Glende & Lee, 1985; Plaa et al, 1982). This effect appears to be due to reduced metabolism of CC14, and appears to be due to the acetone metabolite (Plaa et al, 1982). Caution should be used when isopropyl alcohol is used concurrently with carbon tetrachloride in an industrial setting.

Genitourinary

    3.10.2) CLINICAL EFFECTS
    A) ABNORMAL RENAL FUNCTION
    1) WITH POISONING/EXPOSURE
    a) Renal insufficiency including anuria, followed by oliguria, nitrogen retention, and edema may be a complication of isopropyl poisoning (Hathaway et al, 1996a).
    B) SERUM CREATININE RAISED
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 54–year-old man with a history of alcohol abuse, diabetes mellitus, and hypertension presented to the emergency department on 3 occasions in a 5-month period after ingestion of isopropyl alcohol. On each occasion, the patient was found to have elevated serum creatinines up to 3.6 mg/dL over his baseline serum creatinine of 1.0 mg/dL. He was treated conservatively with intravenous fluids, and on each occasion his serum creatinine levels returned to baseline (Zaman et al, 2002).
    C) CRUSH SYNDROME
    1) WITH POISONING/EXPOSURE
    a) Acute renal tubular necrosis has been reported in a few cases of isopropanol ingestion with associated prolonged hypotension or rhabdomyolysis (Adelson, 1962; Chapin, 1949; Juncos & Taguchi, 1968).
    D) MYOGLOBINURIA
    1) WITH POISONING/EXPOSURE
    a) Myoglobinuria may occur in comatose patients and was reported in 1 patient with rhabdomyolysis (Juncos & Taguchi, 1968).
    3.10.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) RENAL FUNCTION ABNORMAL
    a) Ataxia and microscopic hyaline droplets in the kidneys were seen in male rats exposed to isopropanol at concentrations up to 5000 ppm for 6 hours per day, 5 days per week, for 13 weeks (Burleigh-Flayer et al, 1994b).

Acid-Base

    3.11.2) CLINICAL EFFECTS
    A) KETOSIS
    1) WITH POISONING/EXPOSURE
    a) Ketosis and ketonuria without acidosis is common (Vujasinovic et al, 2007). Normoglycemic ketoacidosis is rare but may occur (Alexander et al, 1982).
    B) METABOLIC ACIDOSIS
    1) WITH POISONING/EXPOSURE
    a) Metabolites of methanol and ethylene glycol can cause metabolic acidosis. Although isopropyl alcohol is metabolized to acetone and does not usually cause metabolic acidosis, it can occur in patients who drink isopropyl alcohol and have decreased caloric intake. Chronic ethanol abusers may present with alcoholic ketoacidosis after a sudden reduction in calorie ntake. Patients with alcoholic ketoacidosis and isopropyl alcohol intoxication may be misdiagnosed with ethanol, methanol, or ethylene glycol intoxication. Fomepizole reduces the clearance of isopropyl alcohol and prolongs its effects; therefore, it is contraindicated in patients with isopropyl alcohol intoxication (Meng et al, 2015).
    1) CASE REPORT: A 45-year-old female chronic ethanol abuser, presented with confusion, agitation, and chest pain after drinking a large amount of alcohol during the previous 2 weeks. Laboratory results revealed a wide plasma osmolal gap (44 mmol/kg) and anion gap metabolic acidosis (15 mmol/L) with elevated serum beta-hydroxybutyric acid levels (3620 mcmol/L), normal serum lactate levels, negligible levels of salicylate and ethanol, and elevated acetone concentration (at least 80 mg/L). Because of a suspicion of ethanol or ethylene glycol intoxication, she was treated with a loading dose of 15 mg/kg of fomepizole; however, she remained confused. Further laboratory analysis revealed elevated isopropyl alcohol concentrations (1.69 mmol/L) and acetone (38 mmol/L). At this time, she admitted to drinking rubbing alcohol and eating little food for several days. Following the discontinuation of fomepizole and continued supportive therapy, including treatment for alcohol withdrawal symptoms, her condition gradually improved and returned to baseline mental and functional status after 3 days (Meng et al, 2015).

Hematologic

    3.13.2) CLINICAL EFFECTS
    A) HEMOLYSIS
    1) WITH POISONING/EXPOSURE
    a) Possible red blood cell hemolysis (hematocrit 31.9% and urine red) developed in an adult following accidental infusion of 35% isopropyl alcohol (800 mL) in saline. Complete recovery occurred following hemodialysis without sequelae (Manring et al, 1997).

Dermatologic

    3.14.2) CLINICAL EFFECTS
    A) DERMATITIS
    1) WITH POISONING/EXPOSURE
    a) Chemical burns have occurred in premature infants following topical application of isopropyl alcohol (Schick & Milstein, 1981; Watkins & Keogh, 1992).
    b) SUSCEPTIBLE POPULATIONS: Persons with preexisting skin disorders may be more susceptible (HSDB, 2003). Premature infants may be at greater risk of developing chemical burns (Schick & Milstein, 1981).
    B) SYSTEMIC DISEASE
    1) WITH POISONING/EXPOSURE
    a) ABSORPTION: Isopropyl alcohol intoxication occurred following dermal absorption in a 21-day-old infant, resulting in seizures, hypotension, lethargy, and CNS depression. The child's mother repeatedly applied cotton soaked with 70% isopropyl alcohol to the umbilicus with every diaper change for 3 weeks (Vivier et al, 1994).
    1) Other cases of significant dermal absorption resulting in toxicity have been reported (Martinez et al, 1986; Mydler et al, 1993).
    3.14.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) SYSTEMIC EFFECTS
    a) DERMAL ABSORPTION: Significant dermal absorption of isopropyl alcohol has been demonstrated in rabbits when inhalational absorption was shown to be negligible (Martinez et al, 1986). Blood levels of isopropyl alcohol after 4 hours of dermal exposure to 70% solution were greater than 100 mg/dL (Martinez et al, 1986).

Musculoskeletal

    3.15.2) CLINICAL EFFECTS
    A) RHABDOMYOLYSIS
    1) WITH POISONING/EXPOSURE
    a) Possible rhabdomyolysis (CK 772 U/L) developed in a 19-year-old man following accidental infusion of 35% isopropyl alcohol (800 mL) in saline. The patient recovered without sequelae following hemodialysis (Manring et al, 1997).

Endocrine

    3.16.2) CLINICAL EFFECTS
    A) HYPERGLYCEMIA
    1) WITH POISONING/EXPOSURE
    a) Mild hyperglycemia is often reported in exposed adults (Lacouture et al, 1983; McCord et al, 1948).
    B) HYPOGLYCEMIA
    1) WITH POISONING/EXPOSURE
    a) Isopropyl alcohol interferes with gluconeogenesis and may result in hypoglycemia (Zaman et al, 2002).
    b) Hypoglycemia might be expected to occur in children.
    C) LACK OF EFFECT
    1) Stephen et al (1997) conducted a retrospective chart review, over a 4-year period, of all children with a discharge diagnosis of isopropyl alcohol ingestion(Stephan et al, 1997). A blood glucose was obtained in 45.7% of the patients, none of whom developed hypoglycemia.

Reproductive

    3.20.1) SUMMARY
    A) At the time of this review, no reproductive studies were found for isopropanol in humans.
    3.20.2) TERATOGENICITY
    A) SUMMARY
    1) The teratogenic potential of isopropanol in humans is unknown.
    B) SKELETAL MALFORMATION
    1) ANIMAL STUDIES
    a) No teratogenic effects were observed in rats inhaling 3500 parts per million (ppm) for 7 hours/day during organogenesis. Exposure to higher concentrations (7000 and 10,000 ppm) produced maternal toxicity and resulted in dose-related decreased fetal weight and increased skeletal malformations. The blood isopropanol levels in nonpregnant rats were shown to be undetectable after exposure to 3500 ppm, 680 mg/dL after exposure to 7000 ppm, and 790 mg/dL after exposure to 10,000 ppm (Nelson et al, 1988).
    b) A 2-generation reproductive study with oral isopropyl alcohol at doses of up to 1000 mg/kg/day revealed effects on neonatal survival and birthweight at maternally toxic doses. No increase in malformations was observed (Bevan et al, 1995).
    c) Skeletal malformations in the offspring of rats have been reported following maternal inhalation exposure to isopropyl alcohol at levels which produced maternal toxicity. Developmental toxicity was not reported in offspring of rats and rabbits in the absence of maternal toxicity (Nelson et al, 1988; Tyl et al, 1994).
    1) Altered mating in male rats and increased postnatal mortality has been demonstrated in a 2-generation study.

Carcinogenicity

    3.21.1) IARC CATEGORY
    A) IARC Carcinogenicity Ratings for CAS67-63-0 (International Agency for Research on Cancer (IARC), 2016; International Agency for Research on Cancer, 2015; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006; IARC, 2004):
    1) IARC Classification
    a) Listed as: Isopropanol
    b) Carcinogen Rating: 3
    1) The agent (mixture or exposure circumstance) is not classifiable as to its carcinogenicity to humans. This category is used most commonly for agents, mixtures and exposure circumstances for which the evidence of carcinogenicity is inadequate in humans and inadequate or limited in experimental animals. Exceptionally, agents (mixtures) for which the evidence of carcinogenicity is inadequate in humans but sufficient in experimental animals may be placed in this category when there is strong evidence that the mechanism of carcinogenicity in experimental animals does not operate in humans. Agents, mixtures and exposure circumstances that do not fall into any other group are also placed in this category.
    2) IARC Classification
    a) Listed as: Isopropanol manufacture (strong-acid process)
    b) Carcinogen Rating: 1
    1) The agent (mixture) is carcinogenic to humans. The exposure circumstance entails exposures that are carcinogenic to humans. This category is used when there is sufficient evidence of carcinogenicity in humans. Exceptionally, an agent (mixture) may be placed in this category when evidence of carcinogenicity in humans is less than sufficient but there is sufficient evidence of carcinogenicity in experimental animals and strong evidence in exposed humans that the agent (mixture) acts through a relevant mechanism of carcinogenicity.
    3.21.2) SUMMARY/HUMAN
    A) Isopropanol is not regarded as a human carcinogen at the present time.
    B) Some studies reported an increased incidence of paranasal, laryngeal, and pharynx cancers, but this was felt to be related to other chemicals used in the manufacture of isopropanol using the strong acid method.
    3.21.3) HUMAN STUDIES
    A) SUMMARY
    1) Isopropanol is not regarded as a human carcinogen at the present time (ACGIH, 2001).
    B) PULMONARY CARCINOMA
    1) RESPIRATORY TRACT NEOPLASMS: Seven cases of neoplasms, including lungs, paranasal sinuses, and vocal cord papillomas were described in workers involved in the production of isopropanol, an incidence of 8.4% of employees exposed for more than 5 years. The suspected carcinogen was a waste byproduct, isopropyl oil (Weil et al, 1952). Similarly, an increased risk of cancer of the larynx, buccal cavity, and pharynx, and 1 case of sinus cancer were reported in workers producing ethanol and isopropyl alcohol by the strong acid process (Teta et al, 1992).
    3.21.4) ANIMAL STUDIES
    A) TESTIS DISORDER
    1) Male rats were found to have a slight increase in interstitial testicular cell adenomas following inhalation exposure (IARC, 1999).
    B) LACK OF EFFECT
    1) Isopropanol was not carcinogenic in mice exposed by inhalation to an airborne concentration of 7700 mg/m(3) for 3 to 7 hours/day, 5 days/week for 5 to 8 months (Weil et al, 1952). It was not carcinogenic in mice exposed to airborne levels up to 5000 parts per million for 6 hours/day, 5 days/week for 18 months (Burleigh-Flayer et al, 1994a; Burleigh-Flayer et al, 1994b).
    2) In rats, a non-dose-related increase in testicular interstitial tumors was noted but is believed to be due to an unusually low incidence of this tumor in controls (Burleigh-Flayer et al, 1997). It was also not carcinogenic by subcutaneous injection in mice given 0.025 mL once per week for 20 to 40 weeks (Weil et al, 1952).
    3) Isopropanol was not carcinogenic in experimental animal testing (Kapp et al, 1996).

Genotoxicity

    A) Isopropanol has not been genotoxic in a variety of short-term tests.

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Monitor vital signs and mental status.
    B) Obtain a metabolic panel, serum isopropyl alcohol and acetone concentrations. Ketonemia and ketonuria may present within 1 to 3 hours of ingestion, but acidosis is NOT expected. Isopropanol elevates measured serum osmolality.
    C) Monitor for evidence of hemorrhagic gastritis (hemoccult stools, gastroccult emesis, hematocrit).
    4.1.2) SERUM/BLOOD
    A) BLOOD/SERUM CHEMISTRY
    1) Isopropyl alcohol is metabolized to acetone. As acetone may contribute to CNS depression, its blood level should also be routinely obtained and followed.
    a) Acetone may be detectable in the urine by 3 hours after ingestion, and in the blood by one-half to 1 hour after isopropyl alcohol ingestion. A presumptive diagnosis can be made with Acetest tablets (Lacouture et al, 1989). As the level of isopropyl alcohol decreases, the concentration of acetone increases and then decreases following elimination.
    b) A high serum or urinary acetone without metabolic acidosis is strongly suggestive of isopropyl alcohol intoxication (Zaman et al, 2002).
    c) DISEASE STATE: Detection of isopropyl alcohol in the blood of a patient with diabetic ketoacidosis was reported, despite denial of any exposure to isopropyl alcohol prior to presentation. It has been suggested that the detection of isopropyl alcohol may be a result of endogenous biotransformation of acetone to isopropyl alcohol in certain disease states, and not due to an acute isopropyl alcohol ingestion (Jones & Summers, 2000).
    2) Monitor serum creatinine and BUN levels. An increased serum creatinine concentration with a normal BUN and acid-base status may suggest a diagnosis of acetone or isopropyl alcohol poisoning (Linden, 1996).
    a) A falsely elevated serum creatinine concentration may occur in the presence of acetonemia when colorimetric methods of analysis are used (Rich et al, 1990) but the BUN measurement is not affected (Linden, 1996).
    3) MONITOR BLOOD GLUCOSE to document the presence or absence of hypoglycemia. Hypoglycemia may be delayed in onset up to several hours postingestion.
    a) The absence of hyperglycemia or glucosuria when acetone is present helps differentiate between alcohol intoxication or diabetic ketoacidosis versus isopropyl alcohol intoxication (Zaman et al, 2002).
    4) OSMOLAL GAP/ESTIMATED BLOOD LEVEL: The absence of an osmolal gap (difference between measured and calculated osmolality) cannot be reliably used to exclude significant isopropanol ingestion. An increased osmolal gap suggests the possibility of toxic alcohol ingestion.
    a) NORMAL OSMOLAL GAP: There are wide variations in what is defined as a normal osmolal gap, depending on the formula used. An individual's osmolal gap may fall within the defined normal range and still be distinctly elevated. Thus, an apparent normal osmolal gap cannot be reliably used to exclude the possibility of isopropanol ingestion (Hoffman et al, 1992).
    b) INCREASED OSMOLAL GAP: The presence of an increased osmolal gap suggests the possibility of a toxic alcohol (including isopropanol) ingestion.
    c) DETERMINATION OF OSMOLAL GAP: Measure the serum osmolality (using the freezing point depression method).
    1) Determine the calculated serum osmolality (Osm-Cal):
                    TRADITIONAL UNITS
       Osm-Cal = 1.86 Na + Glucose + BUN
                           -------   ---
                              18     2.8
                 -----------------------
                            0.93
       where:
        1.86 = osmotic coefficient of Na
          Na = mEq/L MEASURED sodium
     Glucose = mg/dL MEASURED glucose
         BUN = mg/dL MEASURED blood urea nitrogen
          18 = molecular wt glucose/deciliter
               conversion
         2.8 = molecular wt BUN/deciliter conversion
        0.93 = correct for serum water
                           SI UNITS
       Osm-Cal = 1.86 Na + Glucose + BUN
                 -----------------------
                           0.93
       where:
        1.86 = osmotic coefficient of Na
          Na = mmol/L MEASURED sodium
     Glucose = mmol/L MEASURED glucose
         BUN = mmol/L MEASURED blood urea nitrogen
        0.93 = correct for serum water
    

    d) Correct for coingested ethanol (if present) by dividing the measured blood ethanol concentration (in mg/dL) by 4.6 and adding the result to the calculated osmolality before determining the osmolal gap.
    e) Subtract the calculated serum osmolality from the measured serum osmolality to determine the osmolal gap. This difference can be accounted for by the presence of osmotically active substances (including isopropanol).
    f) Osmolal gap x 6 = predicted isopropanol level in mg/dL.
    g) OTHER LIMITATIONS: Methanol, ethylene glycol, ethanol, and acetone can cause an osmolal gap (Cadnapaphornchai et al, 1981).
    5) SI UNIT CONVERSION -
    a) To convert traditional units (mg/dL) into SI units (mmol/L), multiply traditional units by 0.1664.
    b) To convert SI units (mmol/L) into traditional units (mg/dL), divide SI units by 0.1664.
    4.1.3) URINE
    A) Although blood monitoring is preferred for acute isopropyl alcohol ingestion or overdose, urinary acetone may be useful for monitoring industrial exposures (Ghitorri et al, 1996; (Kawai et al, 1990).

Methods

    A) CHROMATOGRAPHY
    1) Gas-liquid chromatography or other specific methodologies may be used to determine isopropyl alcohol levels and levels of its metabolite, acetone(Parker et al, 1962; Baselt, 1997).
    2) Because of its ability to differentiate the different alcohols (methanol, ETOH, isopropyl alcohol, and ethylene glycol), gas chromatography is the lab test of choice (Zaman et al, 2002).
    3) ISOPROPANOL INTERFERENCE WITH BREATH ALCOHOL ANALYSIS: In 1 case report, an individual was arrested for driving while intoxicated. He provided breath samples in 2 different BAC Verifier Datamaster infrared breath alcohol instruments. The instruments showed ethanol results ranging from 0.09 to 0.17 g/210 L, with corresponding interferant results of 0.02 to 0.06 g/210 L over approximately 3 hours. Gas chromatography revealed blood levels of isopropanol (0.023 g/100 mL), acetone (0.057 g/100 mL), and ethanol (0.076 g/100 mL). GCMS was also used to detect the presence of all 3 compounds in breath. It was concluded that this individual consumed both ethanol and isopropanol, with acetone resulting from the metabolism of isopropanol (Logan et al, 1994).
    B) OTHER
    1) Enzymatic methods employing alcohol dehydrogenase may underestimate isopropyl alcohol concentrations (Vasiliades et al, 1978).
    2) Use of a breathalyzer may be misleading.
    3) A protein nuclear magnetic resonance methodology for isopropyl alcohol and acetone allowed rapid analysis and correlated well with gas chromatographic results (Monaghan et al, 1995).
    4) The Alcol Screen dipstick, designed to detect and determine ethanol concentrations in saliva using an alcohol oxidase reaction, was studied in vitro to determine usefulness for detection of methanol, isopropanol, and ethylene glycol in serum. Isopropanol was completely unreactive, even at the highest concentration tested (200 mg/dL), thereby indicating that this screening test is NOT useful for screening for isopropanol exposure (Hack et al, 2000).

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.1) DISPOSITION/ORAL EXPOSURE
    6.3.1.1) ADMISSION CRITERIA/ORAL
    A) Patients with significant persistent central nervous system toxicity (somnolence, intoxication, coma) should be admitted to an intensive care setting.
    B) CHILDREN: Children who ingest more than 2 ounces of isopropyl alcohol or who develop neurologic symptoms should have an isopropyl alcohol level determined and should be admitted into the hospital (Stremski & Hennes, 2000).
    6.3.1.2) HOME CRITERIA/ORAL
    A) Asymptomatic children (other than mild drowsiness) with an acute inadvertent ingestion may be monitored at home. Children younger than 6 years old who have ingested 30 mL or greater are more likely to become symptomatic and should be referred for evaluation and treatment.
    6.3.1.3) CONSULT CRITERIA/ORAL
    A) Consult the poison center or medical toxicologist for assistance in managing patients with severe toxicity (eg, coma) or in whom the diagnosis is not clear.
    6.3.1.5) OBSERVATION CRITERIA/ORAL
    A) Patients with deliberate ingestions or any patient who manifests symptoms should be sent to a health care facility for observation until symptoms resolve.
    B) CHILDREN: Children who ingest less than 30 mL of isopropyl alcohol and who are asymptomatic following presentation to the emergency department (ED) should be observed for at least 2 hours. Patients who remain clinically asymptomatic or who develop self-limited emesis during the observation period are unlikely to develop clinical toxicity and may be discharged from the ED following the observation period (Stremski & Hennes, 2000).

Monitoring

    A) Monitor vital signs and mental status.
    B) Obtain a metabolic panel, serum isopropyl alcohol and acetone concentrations. Ketonemia and ketonuria may present within 1 to 3 hours of ingestion, but acidosis is NOT expected. Isopropanol elevates measured serum osmolality.
    C) Monitor for evidence of hemorrhagic gastritis (hemoccult stools, gastroccult emesis, hematocrit).

Oral Exposure

    6.5.1) PREVENTION OF ABSORPTION/PREHOSPITAL
    A) The onset of CNS depression usually occurs within 30 minutes of ingestion (Lacouture et al, 1983). Do not induce vomiting.
    B) ACTIVATED CHARCOAL
    1) Do not administer prehospital activated charcoal, because of limited utility and the risk of aspiration if CNS depression develops.
    C) INHALATION EXPOSURE
    1) INHALATION: Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with an inhaled beta2-adrenergic agonist. Consider systemic corticosteroids in patients with significant bronchospasm.
    6.5.2) PREVENTION OF ABSORPTION
    A) Activated charcoal and gastric lavage are not indicated. Consider simple nasogastric tube aspiration for large, recent ingestions if the airway is protected.
    6.5.3) TREATMENT
    A) SUPPORT
    1) MANAGEMENT OF MILD TO MODERATE TOXICITY
    a) Treatment is symptomatic and supportive.
    2) MANAGEMENT OF SEVERE TOXICITY
    a) Treatment is symptomatic and supportive. Critically ill patients will need emergent management of airway, breathing, and circulation. CNS depression may require intubation, and alcohol-induced vasodilation and vomiting may lead to hypotension requiring fluid resuscitation, and rarely vasopressors.
    3) Metabolites of methanol and ethylene glycol can cause metabolic acidosis. Although isopropyl alcohol is metabolized to acetone and does not usually cause metabolic acidosis, metabolic acidosis can occur in patients who drink isopropyl alcohol, experience decreased caloric intake, and develop alcoholic ketoacidosis. Chronic ethanol abusers may present with alcoholic ketoacidosis after a sudden reduction of caloric intake. Patients with alcoholic ketoacidosis and isopropyl alcohol intoxication may be misdiagnosed with ethanol, methanol, or ethylene glycol intoxication. Fomepizole reduces the clearance of isopropyl alcohol and prolongs its effects; therefore, it is contraindicated in patients with isopropyl alcohol intoxication (Meng et al, 2015).
    a) CASE REPORT: A 45-year-old female chronic ethanol abuser, presented with confusion, agitation, and chest pain after drinking a large amount of alcohol during the previous 2 weeks. Laboratory results revealed a wide plasma osmolal gap (44 mmol/kg) and anion gap metabolic acidosis (15 mmol/L) with elevated serum beta-hydroxybutyric acid levels (3620 mcmol/L), normal serum lactate levels, negligible levels of salicylate and ethanol, and elevated acetone concentration (at least 80 mg/L). Because of a suspicion of ethanol or ethylene glycol intoxication, she was treated with a loading dose of 15 mg/kg of fomepizole; however, she remained confused. Further laboratory analysis revealed elevated isopropyl alcohol concentrations (1.69 mmol/L) and acetone (38 mmol/L). At this time, she admitted to drinking rubbing alcohol and eating little food for several days. Following the discontinuation of fomepizole and continued supportive therapy, including treatment for alcohol withdrawal symptoms, her condition gradually improved and returned to baseline mental and functional status after 3 days (Meng et al, 2015).
    B) MONITORING OF PATIENT
    1) Monitor vital signs and mental status.
    2) Obtain a metabolic panel, serum isopropyl alcohol and acetone concentrations; ketonemia and ketonuria may present within 1 to 3 hours of ingestion, but acidosis is NOT expected. Isopropanol elevates measured serum osmolality.
    3) Monitor for evidence of hemorrhagic gastritis (hemoccult stools, gastroccult emesis, hematocrit).
    C) HYPOTENSIVE EPISODE
    1) First administer 10 to 20 mL/kg of isotonic intravenous fluids and place in Trendelenburg position. If the patient is unresponsive to these measures, administer dopamine (first choice) or norepinephrine (second choice).
    2) DOPAMINE
    a) DOSE: Begin at 5 micrograms per kilogram per minute progressing in 5 micrograms per kilogram per minute increments as needed (Prod Info dopamine hcl, 5% dextrose IV injection, 2004). If hypotension persists, dopamine may need to be discontinued and a more potent vasoconstrictor (eg, norepinephrine) should be considered (Prod Info dopamine hcl, 5% dextrose IV injection, 2004).
    b) CAUTION: If ventricular dysrhythmias occur, decrease rate of administration (Prod Info dopamine hcl, 5% dextrose IV injection, 2004). Extravasation may cause local tissue necrosis, administration through a central venous catheter is preferred (Prod Info dopamine hcl, 5% dextrose IV injection, 2004).
    3) NOREPINEPHRINE
    a) PREPARATION: 4 milligrams (1 amp) added to 1000 milliliters of diluent provides a concentration of 4 micrograms/milliliter of norepinephrine base. Norepinephrine bitartrate should be mixed in dextrose solutions (dextrose 5% in water, dextrose 5% in saline) since dextrose-containing solutions protect against excessive oxidation and subsequent potency loss. Administration in saline alone is not recommended (Prod Info norepinephrine bitartrate injection, 2005).
    b) DOSE
    1) ADULT: Dose range: 0.1 to 0.5 microgram/kilogram/minute (eg, 70 kg adult 7 to 35 mcg/min); titrate to maintain adequate blood pressure (Peberdy et al, 2010).
    2) CHILD: Dose range: 0.1 to 2 micrograms/kilogram/minute; titrate to maintain adequate blood pressure (Kleinman et al, 2010).
    3) CAUTION: Extravasation may cause local tissue ischemia, administration by central venous catheter is advised (Peberdy et al, 2010).
    D) AIRWAY MANAGEMENT
    1) May be necessary after large ingestions if the patient’s mental status is so depressed they cannot protect their airway.

Inhalation Exposure

    6.7.1) DECONTAMINATION
    A) Move patient from the toxic environment to fresh air. Monitor for respiratory distress. If cough or difficulty in breathing develops, evaluate for hypoxia, respiratory tract irritation, bronchitis, or pneumonitis.
    B) OBSERVATION: Carefully observe patients with inhalation exposure for the development of any systemic signs or symptoms and administer symptomatic treatment as necessary.
    C) INITIAL TREATMENT: Administer 100% humidified supplemental oxygen, perform endotracheal intubation and provide assisted ventilation as required. Administer inhaled beta-2 adrenergic agonists, if bronchospasm develops. Consider systemic corticosteroids in patients with significant bronchospasm (National Heart,Lung,and Blood Institute, 2007). Exposed skin and eyes should be flushed with copious amounts of water.

Eye Exposure

    6.8.1) DECONTAMINATION
    A) Irrigate with water or normal saline, slit lamp examination if irritation persists.

Dermal Exposure

    6.9.1) DECONTAMINATION
    A) DERMAL DECONTAMINATION
    1) DECONTAMINATION: Remove contaminated clothing and wash exposed area thoroughly with soap and water for 10 to 15 minutes. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).
    6.9.2) TREATMENT
    A) SKIN ABSORPTION
    1) Signs and symptoms of systemic toxicity (CNS depression) may occur following dermal exposure, especially following isopropanol sponge bathing (McFadden & Haddow, 1969; Senz & Goldfarb, 1958; Garrison, 1953; Visudhiphan & Kaufman, 1971; Martinez et al, 1986). Prolonged sponging (4 hours or greater) is commonly reported in such cases but may be due to inhalation rather than to cutaneous absorption.
    2) Dermal burns have been reported in premature infants when isopropyl alcohol has been used for skin disinfection (Watkins & Keogh, 1992; Schick & Milstein, 1981).
    3) Following preoperative skin disinfection with an isopropyl alcohol-containing disinfectant, rapid but prolonged absorption of isopropyl alcohol, with levels as high as 12.2 mg/L (1.2 mg/dL), and increased serum acetone is reported (Wittmann et al, 1992).
    4) Significant dermal absorption of isopropyl alcohol has been demonstrated in a rabbit model when inhalational absorption was shown to be negligible (Martinez et al, 1986). Blood levels of isopropyl alcohol after 4 hours of dermal absorption of a 70% solution were greater than 100 mg/dL (Martinez et al, 1986).
    B) Treatment should include recommendations listed in the ORAL EXPOSURE section when appropriate.

Enhanced Elimination

    A) DIURESIS
    1) Not effective.
    B) HEMODIALYSIS
    1) Hemodialysis could be considered in extreme cases; however, most patients should improve with supportive care. Dialysis should be considered when levels are extremely high (eg greater than 500 to 600 mg/dL) or if hypotension does not respond to fluids and vasopressors.
    2) Hemodialysis has resulted in the reduction of an initial blood level of 440 mg % to 100 mg% in 5 hours (King et al, 1970).
    3) It should be noted, however, that metabolism to acetone is rapid. In 1 report, the average dialysance of isopropyl alcohol and acetone were 137 and 165 mL/min, respectively (Rosansky, 1982).
    4) Hemodialysis removes isopropanol 52 times and acetone 40 times more efficiently than does urinary excretion (Zaman et al, 2002); however, there is no clinical evidence that hemodialysis improves outcome (Trullas et al, 2004).
    C) PERITONEAL DIALYSIS
    1) Peritoneal dialysis appears to be minimally effective. In 1 case report (Mecikalski & Depner, 1982) , peritoneal dialysis increased the total body clearance of isopropanol from 29.6 mL/min to 39 mL/min. The peritoneal clearance for acetone was about 13 mL/min.

Case Reports

    A) INFANT
    1) During postoperative ventilator support in an intensive care unit, a 37-week gestation, 1500 g male infant with multiple dysmorphic features inhaled 70% isopropyl alcohol that was accidentally placed in the humidifier of the ventilator for approximately 2 hours.
    a) The infant appeared stable clinically until about 11.5 hours postexposure when he suddenly became cyanotic, bradycardic, and then asystolic. Cardiopulmonary resuscitation was unsuccessful. Isopropyl alcohol/acetone concentrations at 1, 6, and 10 hours postexposure were 31/10, 22/15, and 15/20 mmol/L, respectively (Vicas & Beck, 1993).
    2) A 21-day-old male infant was admitted to the hospital with signs of hypotonia, lethargy, and unresponsiveness to pain. Isopropanol alcohol and acetone were present in the urine at concentrations of 39 mg/dL and 76 mg/dL, respectively, at 8 hours after admission. He was discharged 3 days later in good condition after supportive care. The mother had been swabbing the umbilicus with isopropyl alcohol during each diaper change (Vivier et al, 1994).
    B) ADULT
    1) A 46-year-old woman was admitted to the hospital with an initial serum isopropyl alcohol level of 200 mg/dL and an acetone level of 12 mg/dL in grade 5 coma, with a systolic blood pressure of 80 mmHg and a rectal temperature of 35 degrees C. Hypotension responded to intravenous fluids. She gradually awakened and was alert and responsive 2 days postingestion (Natowicz et al, 1985).

Summary

    A) Toxic oral dose is about 0.5 to 1 mL/kg of rubbing alcohol (70% isopropyl alcohol) but varies depending on the individual patient and coingestants.
    B) Alcohol naive patients may be far more symptomatic at lower levels. Fatalities have occurred in adults with ingestion of as little as 240 mL, but patients ingesting up to 1 L have recovered with supportive care. There have been reports of toxicity in both children and adults after dermal exposure for fever, which is likely a combination of both skin absorption and inhalation.

Minimum Lethal Exposure

    A) The probable oral lethal dose is 240 to 250 mL, although as little as 100 mL can be fatal, and ingestion of only 20 mL has caused poisoning (ACGIH, 2001; Lewis, 2000).

Maximum Tolerated Exposure

    A) ADULT
    1) Tests on human subjects found that airborne concentrations of 400 parts per million (ppm) caused mild irritation of the eyes, nose, and throat; at 800 ppm, the irritation was not severe, but the majority of subjects found the concentration uncomfortable (ACGIH, 2001; Hathaway et al, 1996).
    a) An adult survived after ingesting 1000 mL of 70% isopropyl alcohol solution (rubbing compound). Hemodialysis and supportive medical treatment were provided (Freireich et al, 1967).
    b) Adults have survived with serum isopropyl alcohol levels of 200 mg/dL with supportive care (Natowicz et al, 1985).
    c) Hemodialyzed patients have survived with serum levels of up to 560 mg/dL (Alexander et al, 1982).
    d) Chronic alcoholics may tolerate very high levels of isopropyl alcohol without development of significant CNS depression (Mendelson et al, 1957).
    B) PEDIATRIC
    1) Pediatric patients have survived (with supportive care) the following serum levels:
    a) 128 mg/dL (Senz & Goldfarb, 1958),
    b) 130 mg/dL (Wise, 1969),
    c) 200 mg/dL (McFadden & Haddow, 1969),
    d) 520 mg/dL (Visudhiphan & Kaufman, 1971).
    2) A 21-day-old infant survived (with supportive medical treatment) an estimated dermal exposure to 177 mL of 70% isopropyl alcohol (rubbing alcohol) applied to the umbilicus over a period of 3 weeks.
    a) Urinary isopropyl alcohol and acetone levels were 39 mg/dL and 76 mg/dL of acetone, respectively. Serum isopropyl alcohol and acetone concentrations were 8 mg/dL and 203 mg/dL, respectively, 17 hours after admission (Vivier et al, 1994).

Serum Plasma Blood Concentrations

    7.5.2) TOXIC CONCENTRATIONS
    A) TOXIC CONCENTRATION LEVELS
    1) CONCENTRATION LEVEL
    a) Isopropyl alcohol produces greater CNS depression than ethanol at comparable blood concentrations (Wallgren, 1960). Toxic effects generally occur with concentrations between 50 and 100 mg/dL. Death has been reported at 150 mg/dL, while levels to 440 mg/dL have survived following treatment with hemodialysis.
    b) Blood concentrations of 150 mg/dL: coma likely (McCord et al, 1948)
    c) Blood concentrations greater than 200 mg/dL: generally fatal if no medical treatment is provided.
    2) CASE REPORTS
    a) ADULT
    1) In 3 adult patients who died following isopropanol poisoning, the postmortem blood isopropanol concentrations ranged from 10 to 250 mg/dL with a mean of 140 mg/dL; acetone concentrations ranged from 40 to 300 mg/dL with a mean of 170 mg/dL (Alexander et al, 1982).
    2) A 43-year-old man with alcoholism became hypotensive and delirious after drinking an unknown amount of a hand sanitizer containing isopropanol (63% v/v). His isopropanol and acetone levels were 13.6 mg/dL and 269.4 mg/dL (normal range, 0 to 1.9 for both), respectively. Following supportive therapy, he recovered completely (Emadi & Coberly, 2007).
    3) After ingesting rubbing alcohol, a 38-year-old man with a history of paranoid schizophrenia and suicide attempts developed coma and the presence of skew eye deviation (left eye lower than right) mimicking basilar artery thrombosis. Motor examination revealed flaccid tetraplegia with no response to noxious stimuli. Deep tendon reflexes were hypoactive in the upper and absent in the lower extremities without response to plantar stimulation. Brain CT angiography revealed a patent basilar artery. Gas chromatography revealed an isopropanol level of 287 mg/dL with an acetone level of 123 mg/dL. Following supportive therapy, he recovered over the next 48 hours (Mueller-Kronast et al, 2003).
    b) PEDIATRIC
    1) INFANT: Isopropyl alcohol/acetone concentrations at 1, 6, and 10 hours post exposure were 31/10, 22/15, and 15/20 mmol/L, respectively, in a 37-week child who died 11.5 hours postexposure (Vicas & Beck, 1993).
    2) TODDLER: A 2-year-old boy developed hemorrhagic gastritis after topical isopropanol exposure. His grandmother used isopropanol (half of a 240 mL bottle of isopropanol 70%) sponge-bathing as remedy to reduce his fever. Following supportive therapy, he recovered without further sequelae. Serum isopropanol and acetone levels were 92 mg/dL (normal 0), and 181 mg/dL (normal 0), respectively (Dyer et al, 2002).
    3) TODDLER: Isopropyl alcohol toxicity developed in a 4-year-old girl who was bathed in a preparation of chamomile and isopropyl alcohol during a Mexican folk healing ritual (curanderismo, to treat evil spirits). Serum isopropanol and acetone levels were 9 mg/dL and 146 mg/dL, respectively (DeBellonia et al, 2008).
    4) ADOLESCENT: A 12-year-old girl developed fatal isopropyl alcohol toxicity after ingesting an unknown amount at a party. The girl presented to the hospital approximately 30 hours after the party with somnolence, vomiting and the inability to walk. A few hours after admission, she developed areactive mydriasis, coma and cardiac collapse leading to death. Postmortem serum isopropyl alcohol and acetone levels (measured approximately 36 hours after ingestion) were urine 8.3 mg/L and 631 mg/L, gastric contents 21.7 mg/L and 37.9 mg/L, liver 52.6 mcg/g and 13.2 mcg/g and brain 4.8 mcg/g and 36.3 mcg/g, respectively(Gaulier et al, 2011).

Workplace Standards

    A) ACGIH TLV Values for CAS67-63-0 (American Conference of Governmental Industrial Hygienists, 2010):
    1) Editor's Note: The listed values are recommendations or guidelines developed by ACGIH(R) to assist in the control of health hazards. They should only be used, interpreted and applied by individuals trained in industrial hygiene. Before applying these values, it is imperative to read the introduction to each section in the current TLVs(R) and BEI(R) Book and become familiar with the constraints and limitations to their use. Always consult the Documentation of the TLVs(R) and BEIs(R) before applying these recommendations and guidelines.
    a) Adopted Value
    1) Isopropanol
    a) TLV:
    1) TLV-TWA:
    2) TLV-STEL:
    3) TLV-Ceiling:
    b) Notations and Endnotes:
    1) Carcinogenicity Category: Not Listed
    2) Codes: Not Listed
    3) Definitions: Not Listed
    c) TLV Basis - Critical Effect(s):
    d) Molecular Weight:
    1) For gases and vapors, to convert the TLV from ppm to mg/m(3):
    a) [(TLV in ppm)(gram molecular weight of substance)]/24.45
    2) For gases and vapors, to convert the TLV from mg/m(3) to ppm:
    a) [(TLV in mg/m(3))(24.45)]/gram molecular weight of substance
    e) Additional information:
    1) Name change; see 2-Propanol
    b) Adopted Value
    1) 2-Propanol
    a) TLV:
    1) TLV-TWA: 200 ppm
    2) TLV-STEL: 400 ppm
    3) TLV-Ceiling:
    b) Notations and Endnotes:
    1) Carcinogenicity Category: A4
    2) Codes: Not Listed
    3) Definitions:
    a) A4: Not Classifiable as a Human Carcinogen: Agents which cause concern that they could be carcinogenic for humans but which cannot be assessed conclusively because of a lack of data. In vitro or animal studies do not provide indications of carcinogenicity which are sufficient to classify the agent into one of the other categories.
    c) TLV Basis - Critical Effect(s): Eye and URT irr; CNS impair
    d) Molecular Weight: 60.09
    1) For gases and vapors, to convert the TLV from ppm to mg/m(3):
    a) [(TLV in ppm)(gram molecular weight of substance)]/24.45
    2) For gases and vapors, to convert the TLV from mg/m(3) to ppm:
    a) [(TLV in mg/m(3))(24.45)]/gram molecular weight of substance
    e) Additional information:

    B) NIOSH REL and IDLH Values for CAS67-63-0 (National Institute for Occupational Safety and Health, 2007):
    1) Listed as: Isopropyl alcohol
    2) REL:
    a) TWA: 400 ppm (980 mg/m(3))
    b) STEL: 500 ppm (1225 mg/m(3))
    c) Ceiling:
    d) Carcinogen Listing: (Not Listed) Not Listed
    e) Skin Designation: Not Listed
    f) Note(s):
    3) IDLH:
    a) IDLH: 2000 ppm
    b) Note(s): [10%LEL]
    1) [10%LEL]: The 10%LEL designation is provided where the IDLH was based on 10% of the lower explosive limit. This is used for safety purposes in some cases even though toxicity is not indicative of irreversible health effects or impairment of escape exists only at higher concentrations.

    C) Carcinogenicity Ratings for CAS67-63-0 :
    1) ACGIH (American Conference of Governmental Industrial Hygienists, 2010): Not Listed ; Listed as: Isopropanol
    2) ACGIH (American Conference of Governmental Industrial Hygienists, 2010): A4 ; Listed as: 2-Propanol
    a) A4 :Not Classifiable as a Human Carcinogen: Agents which cause concern that they could be carcinogenic for humans but which cannot be assessed conclusively because of a lack of data. In vitro or animal studies do not provide indications of carcinogenicity which are sufficient to classify the agent into one of the other categories.
    3) EPA (U.S. Environmental Protection Agency, 2011): Not Listed
    4) IARC (International Agency for Research on Cancer (IARC), 2016; International Agency for Research on Cancer, 2015; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006; IARC, 2004): 3 ; Listed as: Isopropanol
    a) 3 : The agent (mixture or exposure circumstance) is not classifiable as to its carcinogenicity to humans. This category is used most commonly for agents, mixtures and exposure circumstances for which the evidence of carcinogenicity is inadequate in humans and inadequate or limited in experimental animals. Exceptionally, agents (mixtures) for which the evidence of carcinogenicity is inadequate in humans but sufficient in experimental animals may be placed in this category when there is strong evidence that the mechanism of carcinogenicity in experimental animals does not operate in humans. Agents, mixtures and exposure circumstances that do not fall into any other group are also placed in this category.
    5) IARC (International Agency for Research on Cancer (IARC), 2016; International Agency for Research on Cancer, 2015; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2010a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2008; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006; IARC, 2004): 1 ; Listed as: Isopropanol manufacture (strong-acid process)
    a) 1 : The agent (mixture) is carcinogenic to humans. The exposure circumstance entails exposures that are carcinogenic to humans. This category is used when there is sufficient evidence of carcinogenicity in humans. Exceptionally, an agent (mixture) may be placed in this category when evidence of carcinogenicity in humans is less than sufficient but there is sufficient evidence of carcinogenicity in experimental animals and strong evidence in exposed humans that the agent (mixture) acts through a relevant mechanism of carcinogenicity.
    6) NIOSH (National Institute for Occupational Safety and Health, 2007): Not Listed ; Listed as: Isopropyl alcohol
    7) MAK (DFG, 2002): Not Listed
    8) NTP (U.S. Department of Health and Human Services, Public Health Service, National Toxicology Project ): Not Listed

    D) OSHA PEL Values for CAS67-63-0 (U.S. Occupational Safety, and Health Administration (OSHA), 2010):
    1) Listed as: Isopropyl alcohol
    2) Table Z-1 for Isopropyl alcohol:
    a) 8-hour TWA:
    1) ppm: 400
    a) Parts of vapor or gas per million parts of contaminated air by volume at 25 degrees C and 760 torr.
    2) mg/m3: 980
    a) Milligrams of substances per cubic meter of air. When entry is in this column only, the value is exact; when listed with a ppm entry, it is approximate.
    3) Ceiling Value:
    4) Skin Designation: No
    5) Notation(s): Not Listed

Toxicity Information

    7.7.1) TOXICITY VALUES
    A) References: Lewis, 2000; RTECS, 2003
    1) LD50- (INTRAPERITONEAL)MOUSE:
    a) 4477 mg/kg
    2) LD50- (ORAL)MOUSE:
    a) 3600 mg/kg
    3) LD50- (INTRAPERITONEAL)RAT:
    a) 2735 mg/kg
    4) LD50- (ORAL)RAT:
    a) 5045 mg/kg
    5) TCLo- (INHALATION)RAT:
    a) 10,000 ppm for 7H

Toxicologic Mechanism

    A) Isopropyl alcohol must be distinguished from n-propyl alcohol. Metabolism is hepatic and results in the formation of acetone, which in turn may be metabolized to acetate and carbon dioxide. Acetone may contribute to the CNS depression seen in isopropyl alcohol poisoning.

Physical Characteristics

    A) Isopropanol is a colorless, flammable liquid with a slight odor resembling rubbing alcohol and a slightly bitter taste (ACGIH, 2001; Ashford, 2001; Budavari, 1996; Lewis, 2001; Lewis, 2000).

Ph

    1) No information found at the time of this review.

Molecular Weight

    A) 60.10

Clinical Effects

    11.1.13) OTHER
    A) OTHER
    1) Initially, emesis, hematemesis, and abdominal tenderness occur, followed by CNS and respiratory depression. Hypotensive shock, ketonemia, ketosuria, and high anion gap acidosis may also be seen (Coppock et al, 1988).

Treatment

    11.2.1) SUMMARY
    A) GENERAL TREATMENT
    1) SUMMARY
    a) Begin treatment immediately.
    b) Keep animal warm and do not handle unnecessarily.
    c) Remove the patient and other animals from the source of contamination or remove dietary sources.
    2) Treatment should always be done on the advice and with the consultation of a veterinarian.
    3) Additional information regarding treatment of poisoned animals may be obtained from a Veterinary Toxicologist or the National Animal Poison Control Center.
    4) ASPCA ANIMAL POISON CONTROL CENTER
    a) ASPCA Animal Poison Control Center, 1717 S Philo Road, Suite 36 Urbana, IL 61802
    b) It is an emergency telephone service which provides toxicology information to veterinarians, animal owners, universities, extension personnel and poison center staff for a fee. A veterinary toxicologist is available for consultation.
    c) Contact information: (888) 426-4435 (hotline) or www.aspca.org (A fee may apply. Please inquire with the poison center). The agency will make follow-up calls as needed in critical cases at no extra charge.
    5) SMALL ANIMALS: Due to lack of reports of large animal intoxication with this substance, the following sections address small animals (dogs and cats) only.
    6) In the case of a poisoning involving large animals, consult a veterinary poison control center.
    11.2.2) LIFE SUPPORT
    A) GENERAL
    1) MAINTAIN VITAL FUNCTIONS: Secure airway, supply oxygen, and begin supportive fluid therapy if necessary.
    11.2.4) DECONTAMINATION
    A) GASTRIC DECONTAMINATION
    1) GENERAL TREATMENT
    a) EMESIS/GASTRIC LAVAGE -
    1) Emesis is not recommended unless within 25 to 30 minutes of ingestion.
    2) CAUTION: Carefully examine patients with chemical exposure before inducing emesis. If signs of oral, pharyngeal, or esophageal irritation, a depressed gag reflex, or central nervous system excitation or depression are present, EMESIS SHOULD NOT BE INDUCED.
    3) HORSES OR CATTLE: DO NOT attempt to induce emesis in ruminants (cattle) or equids (horses).
    4) DOGS AND CATS
    a) IPECAC: If within 2 hours of exposure: induce emesis with 1 to 2 milliliters/kilogram syrup of ipecac per os.
    b) APOMORPHINE: Dogs may vomit more readily with 1 tablet (6 milligrams) apomorphine diluted in 3 to 5 milliliters water and instilled into the conjunctival sac or per os.
    1) Dogs may also be given apomorphine intravenously at 40 micrograms/kilogram, although this route may not be as effective.
    5) LAVAGE: In the absence of a gag reflex or if vomiting cannot be induced, place a cuffed endotracheal tube and begin gastric lavage.
    a) Pass large bore stomach tube and instill 5 to 10 milliliters/kilogram water or lavage solution, then aspirate. Repeat 10 times.
    b) ACTIVATED CHARCOAL/CATHARTIC -
    1) ACTIVATED CHARCOAL: Administer activated charcoal. Dose: 2 grams/kilogram per os or via stomach tube. Avoid aspiration by proper restraint, careful technique, and if necessary tracheal intubation.
    2) CATHARTIC: Administer a dose of a saline or sorbitol cathartic such as magnesium or sodium sulfate (sodium sulfate dose is 1 gram/kilogram). If access to these agents is limited, give 5 to 15 milliliters magnesium oxide (Milk of Magnesia) per os for dilution.
    11.2.5) TREATMENT
    A) GENERAL TREATMENT
    1) MAINTAIN VITAL FUNCTIONS as necessary.
    2) Begin electrolyte and fluid therapy with isotonic solutions as needed at maintenance doses (66 milliliters solution/kilogram body weight/day intravenously) or, in hypotensive patients, at high doses (up to shock dose 60 milliliters/kilogram/hour). Monitor for urine production and pulmonary edema.
    3) BICARBONATE: Add sodium bicarbonate to the intravenous fluids if metabolic acidosis is suspected. (If using lactated ringers solution and precipitate forms upon addition of bicarbonate, discard and substitute a different solution).
    a) Formula for bicarbonate addition when blood gases are available: milliequivalents bicarbonate added = base deficit x 0.5 x body weight in kilograms. Give one half of the determined dose slowly over 3 to 4 hours intravenously; titrate as needed.
    b) Continue to dose based on blood gas determinations. When blood gases are not available and patient is symptomatic, administer 1 to 4 milliequivalents/kilogram intravenously slowly over 4 to 8 hours.
    4) ENHANCED ELIMINATION -
    a) Peritoneal or hemodialysis for 5 hours or longer may be the most effective way to remove this toxin (Coppock et al, 1988).
    5) MONITORING -
    a) Admit all symptomatic patients and begin treatment.
    b) Unless life threatening signs develop, these patients may be kept in the primary care clinic (24 hour monitoring is not necessary).
    6) FOLLOW-UP -
    a) Instruct the owner to return for a follow up appointment at which physical examination and appropriate laboratory tests will be repeated.

Continuing Care

    11.4.1) SUMMARY
    11.4.1.2) DECONTAMINATION/TREATMENT
    A) GENERAL TREATMENT
    1) SUMMARY
    a) Begin treatment immediately.
    b) Keep animal warm and do not handle unnecessarily.
    c) Remove the patient and other animals from the source of contamination or remove dietary sources.
    2) Treatment should always be done on the advice and with the consultation of a veterinarian.
    3) Additional information regarding treatment of poisoned animals may be obtained from a Veterinary Toxicologist or the National Animal Poison Control Center.
    4) ASPCA ANIMAL POISON CONTROL CENTER
    a) ASPCA Animal Poison Control Center, 1717 S Philo Road, Suite 36 Urbana, IL 61802
    b) It is an emergency telephone service which provides toxicology information to veterinarians, animal owners, universities, extension personnel and poison center staff for a fee. A veterinary toxicologist is available for consultation.
    c) Contact information: (888) 426-4435 (hotline) or www.aspca.org (A fee may apply. Please inquire with the poison center). The agency will make follow-up calls as needed in critical cases at no extra charge.
    5) SMALL ANIMALS: Due to lack of reports of large animal intoxication with this substance, the following sections address small animals (dogs and cats) only.
    6) In the case of a poisoning involving large animals, consult a veterinary poison control center.
    11.4.2) DECONTAMINATION
    11.4.2.2) GASTRIC DECONTAMINATION
    A) GASTRIC DECONTAMINATION
    1) GENERAL TREATMENT
    a) EMESIS/GASTRIC LAVAGE -
    1) Emesis is not recommended unless within 25 to 30 minutes of ingestion.
    2) CAUTION: Carefully examine patients with chemical exposure before inducing emesis. If signs of oral, pharyngeal, or esophageal irritation, a depressed gag reflex, or central nervous system excitation or depression are present, EMESIS SHOULD NOT BE INDUCED.
    3) HORSES OR CATTLE: DO NOT attempt to induce emesis in ruminants (cattle) or equids (horses).
    4) DOGS AND CATS
    a) IPECAC: If within 2 hours of exposure: induce emesis with 1 to 2 milliliters/kilogram syrup of ipecac per os.
    b) APOMORPHINE: Dogs may vomit more readily with 1 tablet (6 milligrams) apomorphine diluted in 3 to 5 milliliters water and instilled into the conjunctival sac or per os.
    1) Dogs may also be given apomorphine intravenously at 40 micrograms/kilogram, although this route may not be as effective.
    5) LAVAGE: In the absence of a gag reflex or if vomiting cannot be induced, place a cuffed endotracheal tube and begin gastric lavage.
    a) Pass large bore stomach tube and instill 5 to 10 milliliters/kilogram water or lavage solution, then aspirate. Repeat 10 times.
    b) ACTIVATED CHARCOAL/CATHARTIC -
    1) ACTIVATED CHARCOAL: Administer activated charcoal. Dose: 2 grams/kilogram per os or via stomach tube. Avoid aspiration by proper restraint, careful technique, and if necessary tracheal intubation.
    2) CATHARTIC: Administer a dose of a saline or sorbitol cathartic such as magnesium or sodium sulfate (sodium sulfate dose is 1 gram/kilogram). If access to these agents is limited, give 5 to 15 milliliters magnesium oxide (Milk of Magnesia) per os for dilution.

General Bibliography

    1) 40 CFR 372.28: Environmental Protection Agency - Toxic Chemical Release Reporting, Community Right-To-Know, Lower thresholds for chemicals of special concern. National Archives and Records Administration (NARA) and the Government Printing Office (GPO). Washington, DC. Final rules current as of Apr 3, 2006.
    2) 40 CFR 372.65: Environmental Protection Agency - Toxic Chemical Release Reporting, Community Right-To-Know, Chemicals and Chemical Categories to which this part applies. National Archives and Records Association (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Apr 3, 2006.
    3) 49 CFR 172.101 - App. B: Department of Transportation - Table of Hazardous Materials, Appendix B: List of Marine Pollutants. National Archives and Records Administration (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Aug 29, 2005.
    4) 49 CFR 172.101: Department of Transportation - Table of Hazardous Materials. National Archives and Records Administration (NARA) and the Government Printing Office (GPO), Washington, DC. Final rules current as of Aug 11, 2005.
    5) 62 FR 58840: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 1997.
    6) 65 FR 14186: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    7) 65 FR 39264: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    8) 65 FR 77866: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2000.
    9) 66 FR 21940: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2001.
    10) 67 FR 7164: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2002.
    11) 68 FR 42710: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2003.
    12) 69 FR 54144: Notice of the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances - Proposed AEGL Values, Environmental Protection Agency, NAC/AEGL Committee. National Archives and Records Administration (NARA) and the Government Publishing Office (GPO), Washington, DC, 2004.
    13) AAR: Emergency Handling of Hazardous Materials in Surface Transportation, Bureau of Explosives, Association of American Railroads, Washington, DC, 2000.
    14) ACGIH: Documentation of the Threshold Limit Values and Biological Exposure Indices, 7th ed, Am Conference of Govt Ind Hyg, Inc, Cincinnati, OH, 2001.
    15) ACGIH: Documentation of the Treshold Limit Values and Biological Exposure Indices, 6th ed, Am Conference of Govt Ind Hyg, Inc, Cincinnati, OH, 1991.
    16) AIHA: 2006 Emergency Response Planning Guidelines and Workplace Environmental Exposure Level Guides Handbook, American Industrial Hygiene Association, Fairfax, VA, 2006.
    17) Adelson L: Fatal intoxication with isopropyl alcohol (rubbing alcohol). Am J Clin Pathol 1962; 38:144-151.
    18) Alexander CB, McBay AJ, & Hudson RP: Isopropanol and isopropanol deaths -- ten years experience. J Forens Sci 1982; 27:541-548.
    19) Allen B, Gentry R, & Shipp A: Calculation of benchmark doses for reproductive and developmental toxicity observed after exposure to isopropanol. Regul Toxicol Pharmacol 1998; 28(1):38-44.
    20) American Conference of Governmental Industrial Hygienists : ACGIH 2010 Threshold Limit Values (TLVs(R)) for Chemical Substances and Physical Agents and Biological Exposure Indices (BEIs(R)), American Conference of Governmental Industrial Hygienists, Cincinnati, OH, 2010.
    21) Ansell-Edmont: SpecWare Chemical Application and Recommendation Guide. Ansell-Edmont. Coshocton, OH. 2001. Available from URL: http://www.ansellpro.com/specware. As accessed 10/31/2001.
    22) Ashford R: Ashford's Dictionary of Industrial Chemicals, 2nd ed, Wavelength Publications Ltd, London, England, 2001.
    23) Ashford R: Ashford's Dictionary of Industrial Chemicals, Wavelength Publications Ltd, London, England, 1994.
    24) Barnett JM, Plotnick M, & Fine KC: Intoxication after an isopropyl alcohol enema (Editorial). Ann Intern Med 1990; 113:638-639.
    25) Baselt RC: Biological Monitoring Methods for Industrial Chemicals. 3rd ed, PSG Publishing Co, Littleton, MA, 1997.
    26) Baselt RC: Disposition of Toxic Drugs and Chemicals in Man, 5th ed, Chemical Toxicology Institute, Foster City, CA, 2000.
    27) Bata Shoe Company: Industrial Footwear Catalog, Bata Shoe Company, Belcamp, MD, 1995.
    28) Bates HK, McKee RH, & Bieler GS: Developmental neurotoxicity evaluation of orally administered isopropanol in rats. Fundam Appl Toxicol 1994; 22:152-158.
    29) Bekka R, Borron SW, & Astier A: Treatment of methanol and isopropanol poisoning with intravenous fomepizole. Clin Toxicol 2001; 39:59-67.
    30) Best Manufacturing: ChemRest Chemical Resistance Guide. Best Manufacturing. Menlo, GA. 2002. Available from URL: http://www.chemrest.com. As accessed 10/8/2002.
    31) Best Manufacturing: Degradation and Permeation Data. Best Manufacturing. Menlo, GA. 2004. Available from URL: http://www.chemrest.com/DomesticPrep2/. As accessed 04/09/2004.
    32) Bevan C, Tyler TR, & Gardiner TH: Two-generation reproduction toxicity study with isopropanol in rats. J Appl Toxicol 1995; 15:117-123.
    33) Bingham E, Cohrssen B, & Powell CH: Patty's Toxicology Vol. 6, 5th ed, John Wiley & Sons, Inc, New York, NY, 2001.
    34) Blow BJ, Ge Y, & Safdar Z: Respiratory failure, lung infiltrates, and hemoptysis in a woman with chronic isopropyl alcohol inhalation. Ther Adv Respir Dis 2012; 6(3):189-193.
    35) Boatman RJ, Perry LG, & Fiorica LA: Dermal absorption and pharmacokinetics of isopropanol in the male and female F-344 rat. Drug Metab Disp 1998; 26(3):197-202.
    36) Boss Manufacturing Company: Work Gloves, Boss Manufacturing Company, Kewanee, IL, 1998.
    37) Brown JA: Incorrectly dropped in the eye. Aust Prescr 2013; 36:56.
    38) Budavari S: The Merk Index, 12th ed, Merck & Co, Inc, Whitehouse Station, NJ, 1996.
    39) Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212.
    40) Burleigh-Flayer H, Beyan C, & Gardiner T: Isopropanol vapor inhalation oncogenicity in CD-1 mice. Toxicologist 1994a; 14:1219.
    41) Burleigh-Flayer H, Garman R, & Neptun D: Isopropanol vapor inhalation oncogenicity study in Fischer 344 rats and CD-1 mice. Fundam Appl Toxicol 1997; 36:95-11.
    42) Burleigh-Flayer HD, Gill MW, & Strother DE: Isopropanol 13-week vapor inhalation study in rats and mice with neurotoxicity evaluation in rats. Fundam Appl Toxicol 1994b; 23:421-428.
    43) Chan KM, Wong ET, & Matthews WS: Severe isopropanolemia without acetonemia or clinical manifestations of isopropanol intoxication. Clin Chem 1993; 39:1922-1925.
    44) Chapin MA: Isopropyl alcohol poisoning with acute renal insufficiency. J Maine Med Assoc 1949; 40:288-290.
    45) ChemFab Corporation: Chemical Permeation Guide Challenge Protective Clothing Fabrics, ChemFab Corporation, Merrimack, NH, 1993.
    46) Clayton GD & Clayton FE: Patty's Industrial Hygiene and Toxicology, Vol 2D, Toxicology, 4th ed, John Wiley & Sons, New York, NY, 1994, pp 2627-2635.
    47) Comasec Safety, Inc.: Chemical Resistance to Permeation Chart. Comasec Safety, Inc.. Enfield, CT. 2003. Available from URL: http://www.comasec.com/webcomasec/english/catalogue/mtabgb.html. As accessed 4/28/2003.
    48) Comasec Safety, Inc.: Product Literature, Comasec Safety, Inc., Enfield, CT, 2003a.
    49) Coppock RW, Mostrom MS, & Lillie LE: The toxicology of detergents, bleaches, antiseptics and disinfectants in small animals. Vet Human Toxicol 1988; 30:463-473.
    50) Corbett J & Meier G: Suicide attempted by rectal administration of drug. JAMA 1968; 206:2320-2321.
    51) DFG: List of MAK and BAT Values 2002, Report No. 38, Deutsche Forschungsgemeinschaft, Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area, Wiley-VCH, Weinheim, Federal Republic of Germany, 2002.
    52) Daniel DR, McAnalley BH, & Garriott JC: Isopropyl alcohol metabolism after acute intoxication in humans. J Anal Toxicol 1981; 5:110-112.
    53) Davis PL, Dal Cortivo LA, & Maturo J: Endogenous isopropanol: forensic and biochemical implications. J Anal Toxicol 1984; 8:209-212.
    54) DeBellonia RR, Marcus S, Shih R, et al: Curanderismo: consequences of folk medicine. Pediatr Emerg Care 2008; 24(4):228-229.
    55) Deng JF, Wang JD, & Shih TS: Outbreak of carbon tetrachloride poisoning in a color printing factory related to the use of isopropyl alcohol and an air conditioning system in Taiwan. Am J Ind Med 1987; 12:11-19.
    56) Dhillon S & Von Burg R: Toxicology Update: Isopropyl Alcohol. J Appl Toxicol 1995; 15:501-506.
    57) DuPont: DuPont Suit Smart: Interactive Tool for the Selection of Protective Apparel. DuPont. Wilmington, DE. 2002. Available from URL: http://personalprotection.dupont.com/protectiveapparel/suitsmart/smartsuit2/na_english.asp. As accessed 10/31/2002.
    58) DuPont: Permeation Guide for DuPont Tychem Protective Fabrics. DuPont. Wilmington, DE. 2003. Available from URL: http://personalprotection.dupont.com/en/pdf/tyvektychem/pgcomplete20030128.pdf. As accessed 4/26/2004.
    59) DuPont: Permeation Test Results. DuPont. Wilmington, DE. 2002a. Available from URL: http://www.tyvekprotectiveapprl.com/databases/default.htm. As accessed 7/31/2002.
    60) Dyer S, Mycyk MB, Ahrens WR, et al: Hemorrhagic gastritis from topical isopropanol exposure. Ann Pharmacother 2002; 36:1733-1735.
    61) EPA: Chemical Hazard Information Profile (Draft), Environmental Protection Agency, Washington, DC, 1979, pp 12.
    62) EPA: Search results for Toxic Substances Control Act (TSCA) Inventory Chemicals. US Environmental Protection Agency, Substance Registry System, U.S. EPA's Office of Pollution Prevention and Toxics. Washington, DC. 2005. Available from URL: http://www.epa.gov/srs/.
    63) ERG: Emergency Response Guidebook. A Guidebook for First Responders During the Initial Phase of a Dangerous Goods/Hazardous Materials Incident, U.S. Department of Transportation, Research and Special Programs Administration, Washington, DC, 2004.
    64) Emadi A & Coberly L: Intoxication of a hospitalized patient with an isopropanol-based hand sanitizer. N Engl J Med 2007; 356(5):530-531.
    65) Florin I: Toxicology 1980; 15:219-232.
    66) Folland DS: JAMA 1976; 236:1853-1856.
    67) Freeman HM: Standard Handbook of Hazardous Waste Treatment and Disposal, McGraw-Hill Book Company, New York, NY, 1989.
    68) Freireich AW, Cinque TJ, & Xanthaky G: Hemodialysis for isopropanol poisoning. N Engl J Med 1967; 277:699-700.
    69) Garrison RF: Acute poisoning from use of isopropyl alcohol in tepid sponging. JAMA 1953; 152:317-318.
    70) Gaudet MP & Fraser GL: Isopropanol ingestion: Case report with pharmacokinetic analysis. Am J Emerg Med 1989; 7:297-299.
    71) Gaulier JM, Lamballais F, Yazdani F, et al: Isopropyl alcohol concentrations in postmortem tissues to document fatal intoxication. J Anal Toxicol 2011; 35(4):254-255.
    72) Gill MW, Burleigh-Flayer HD, & Strother DE: Isopropanol: acute vapor inhalation neurotoxicity study in rats. J Appl Toxicol 1995; 15:77-84.
    73) Glende EA Jr & Lee PY: Isopropanol and chlordecone potentiation of carbon tetrachloride liver injury: retention of potentiating action in hepatocyte suspensions prepared from rats given isopropanol or chlordecone. Exp Mol Pathol 1985; 42:167-174.
    74) Goldfrank LR: Goldfrank's Toxicological Emergencies, 7th ed, McGraw-Hill, New York, NY, 2002.
    75) Grant WM & Schuman JS: Toxicology of the Eye, 4th ed, Charles C Thomas, Springfield, IL, 1993.
    76) Guardian Manufacturing Group: Guardian Gloves Test Results. Guardian Manufacturing Group. Willard, OH. 2001. Available from URL: http://www.guardian-mfg.com/guardianmfg.html. As accessed 12/11/2001.
    77) Guseinov VG: Gig Tr Prof Zabol 1985; 7:60-62.
    78) HSDB : Hazardous Substances Data Bank. National Library of Medicine. Bethesda, MD (Internet Version). Edition expires 1999; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    79) HSDB : Hazardous Substances Data Bank. National Library of Medicine. Bethesda, MD (Internet Version). Edition expires 2003; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    80) Hack JB, Chiang WK, & Howland MA: The utility of an alcohol oxidase reaction test to expedite the detection of toxic alcohol exposures. Acad Emerg Med 2000; 7:294-297.
    81) Hahn E: Biochem Zeitschr 1937; 292:148-151.
    82) Hathaway GJ, Proctor NH, & Hughes JP: Chemical Hazards of the Workplace, 3rd ed, Van Nostrand Reinhold Company, New York, NY, 1991.
    83) Hathaway GJ, Proctor NH, & Hughes JP: Chemical Hazards of the Workplace, 4th ed, Van Nostrand Reinhold Company, New York, NY, 1996.
    84) Hathaway GJ, Proctor NH, & Hughes JP: Proctor and Hughes' Chemical Hazards of the Workplace, 4th ed, Van Nostrand Reinhold, New York, NY, 1996a.
    85) Haviv YS, Safadi R, & Osin P: Accidental isopropyl alcohol enema leading to coma and death [letter]. Am J Gastroenterol 1998; 93(5):850-851.
    86) Hoffman RS, Smilkstein MJ, & Howland MA: Osmol gaps revisited: normal values and limitations. Clin Toxicol 1992; 31:81-93.
    87) Howard PH, Boethling RS, & Jarvis WF: Handbook of Environmental Degradation Rates, Lewis Publishers, Chelsea, MI, 1991.
    88) Howard PH: Handbook of Environmental Fate and Exposure Data for Organic Chemicals. Volume II: Solvents, Lewis Publishers, Chelsea, MI, 1990.
    89) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide), 97, International Agency for Research on Cancer, Lyon, France, 2008.
    90) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol, 88, International Agency for Research on Cancer, Lyon, France, 2006.
    91) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Household Use of Solid Fuels and High-temperature Frying, 95, International Agency for Research on Cancer, Lyon, France, 2010a.
    92) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines, 89, International Agency for Research on Cancer, Lyon, France, 2007.
    93) IARC Working Group on the Evaluation of Carcinogenic Risks to Humans : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures, 92, International Agency for Research on Cancer, Lyon, France, 2010.
    94) IARC: Isopropanol. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 71 (part 3), International Agency for Research on Cancer, World Health Organization, Geneva, Switzerland, 1999, pp 1027-1036.
    95) IARC: List of all agents, mixtures and exposures evaluated to date - IARC Monographs: Overall Evaluations of Carcinogenicity to Humans, Volumes 1-88, 1972-PRESENT. World Health Organization, International Agency for Research on Cancer. Lyon, FranceAvailable from URL: http://monographs.iarc.fr/monoeval/crthall.html. As accessed Oct 07, 2004.
    96) ICAO: Technical Instructions for the Safe Transport of Dangerous Goods by Air, 2003-2004. International Civil Aviation Organization, Montreal, Quebec, Canada, 2002.
    97) ILC Dover, Inc.: Ready 1 The Chemturion Limited Use Chemical Protective Suit, ILC Dover, Inc., Frederica, DE, 1998.
    98) IPCS INCHEM: Isopropyl alcohol: Poisons Information Monograph 290. International Programme on Chemical Safety (IPCS); Canadian Centre for Occupational Health and Safety (CCOHS). Geneva, Switzerland. 1990. Available from URL: http://www.inchem.org/documents/pims/chemical/pim290.htm. As accessed 2015-01-06.
    99) ITI: Toxic and Hazardous Industrial Chemicals Safety Manual, The International Technical Information Institute, Tokyo, Japan, 1995.
    100) International Agency for Research on Cancer (IARC): IARC monographs on the evaluation of carcinogenic risks to humans: list of classifications, volumes 1-116. International Agency for Research on Cancer (IARC). Lyon, France. 2016. Available from URL: http://monographs.iarc.fr/ENG/Classification/latest_classif.php. As accessed 2016-08-24.
    101) International Agency for Research on Cancer: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. World Health Organization. Geneva, Switzerland. 2015. Available from URL: http://monographs.iarc.fr/ENG/Classification/. As accessed 2015-08-06.
    102) Jensen O: Contact allergy to propylene oxide and isopropyl alcohol in a skin disinfectant swab. Contact Dematitis 1981; 7:148-150.
    103) Jerrad D, Verdile V, & Yealy D: Serum determinations in toxic isopropanol ingestion. Am J Emerg Med 1992; 10:200-202.
    104) Jones AE & Summers RL: Detection of isopropyl alcohol in a patient with diabetic ketoacidosis. J Emerg Med 2000; 19:165-168.
    105) Jones AW: Elimination half-life of acetone in humans: case reports and review of the literature. J Analyt Toxicol 2000; 24:8-10.
    106) Juncos L & Taguchi JT: Isopropyl alcohol intoxication. JAMA 1968; 204:732-734.
    107) Kapp RW, Bevan C, & Gardiner TH: Isopropanol -- summary of TSCA test rule studies and relevance to hazard identification. Regul Toxicol Pharmacol 1996; 23:183-192.
    108) Kapp RW, Marino DJ, & Gardiner TH: In vitro and in vivo assays of isopropanol for mutagenicity. Environ Mol Mutagen 1993; 22:93-100.
    109) Kappler, Inc.: Suit Smart. Kappler, Inc.. Guntersville, AL. 2001. Available from URL: http://www.kappler.com/suitsmart/smartsuit2/na_english.asp?select=1. As accessed 7/10/2001.
    110) Kawai T, Yasugi T, & Horiguchi S: Biological monitoring of occupational exposure to isopropyl alcohol vapor by urinalysis for acetone. Int Arch Occup Environ Health 1990; 62:409-413.
    111) Kelner M & Bailey DN: Isopropanol ingestion: interpretation of blood concentrations and clinical findings. J Toxicol Clin Toxicol 1983; 20:497-507.
    112) Kemal H: Biochem Zeitschr 1927; 187:461-466.
    113) Kimberly-Clark, Inc.: Chemical Test Results. Kimberly-Clark, Inc.. Atlanta, GA. 2002. Available from URL: http://www.kc-safety.com/tech_cres.html. As accessed 10/4/2002.
    114) King LH, Bradley KP, & Shires DL: Hemodialysis for isopropyl alcohol poisoning. JAMA 1970; 211:1855.
    115) Kleinman ME, Chameides L, Schexnayder SM, et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 14: pediatric advanced life support. Circulation 2010; 122(18 Suppl.3):S876-S908.
    116) LaCrosse-Rainfair: Safety Products, LaCrosse-Rainfair, Racine, WI, 1997.
    117) Lacouture PG, Heldreth DD, & Shannon M: The generation of acetonemia/acetonuria following ingestion of a subtoxic dose of isopropyl alcohol. Am J Emerg Med 1989; 7:38-40.
    118) Lacouture PG, Wason S, & Abrams A: Acute isopropyl alcohol intoxication: diagnosis and management. Am J Med 1983; 75:680-686.
    119) Leblanc AE & Kalant H: Toxicol Appl Pharmacol 1975; 32:123-128.
    120) Lehman AJ & Chase HF: The acute and chronic toxicity of isopropyl alcohol. J Lab Clin Med 1944; 29:561-567.
    121) Lehmann AJ: J Pharmacol Exp Ther 1945; 85:61-69.
    122) Lewis RJ: Hawley's Condensed Chemical Dictionary, 12th ed, Van Nostrand Reinhold Company, New York, NY, 1993.
    123) Lewis RJ: Hawley's Condensed Chemical Dictionary, 13th ed, John Wiley & Sons, Inc, New York, NY, 2001.
    124) Lewis RJ: Sax's Dangerous Properties of Industrial Materials, 10th ed, John Wiley & Sons, Inc, New York, NY, 2000a.
    125) Lewis RJ: Sax's Dangerous Properties of Industrial Materials, 10th ed, John Wiley & Sons, New York, NY, 2000.
    126) Lewis RJ: Sax's Dangerous Properties of Industrial Materials, 9th ed, Van Nostrand Reinhold Company, New York, NY, 1996.
    127) Linden CH: Unknown alcohol (letter). Ann Emerg Med 1996; 28:371.
    128) Logan BK, Gullberg RG, & Elenbaas JK: Isopropanol interference with breath alcohol analysis: a case report. J Forensic Sci 1994; 39(4):1107-1111.
    129) Ludwig E & Hausen BM: Sensitivity to isopropyl alcohol. Contact Dermatitis 1977; 3:240-244.
    130) MAPA Professional: Chemical Resistance Guide. MAPA North America. Columbia, TN. 2003. Available from URL: http://www.mapaglove.com/pro/ChemicalSearch.asp. As accessed 4/21/2003.
    131) MAPA Professional: Chemical Resistance Guide. MAPA North America. Columbia, TN. 2004. Available from URL: http://www.mapaglove.com/ProductSearch.cfm?id=1. As accessed 6/10/2004.
    132) Manring E, Meggs W, & Pape G: Toxicity of an intravenous infusion of isopropyl alcohol. J of Toxicol - Clin Toxicol 1997; 35:503.
    133) Mar-Mac Manufacturing, Inc: Product Literature, Protective Apparel, Mar-Mac Manufacturing, Inc., McBee, SC, 1995.
    134) Marigold Industrial: US Chemical Resistance Chart, on-line version. Marigold Industrial. Norcross, GA. 2003. Available from URL: www.marigoldindustrial.com/charts/uschart/uschart.html. As accessed 4/14/2003.
    135) Martinez TT, Jaeger RW, & DeCastro FJ: A comparison of the absorption and metabolism of isopropyl alcohol by oral, dermal and inhalation routes. Vet Human Toxicol 1986; 28:233-236.
    136) McCord WM, Switzer PK, & Brill HH: Isopropyl alcohol intoxication. South Med J 1948; 41:639-642.
    137) McFadden SW & Haddow JE: Coma produced by topical application of isopropanol. Pediatrics 1969; 43:622-623.
    138) Mecikalski MB & Depner TA: Peritoneal dialysis for isopropanol poisoning. West J Med 1982; 137:322-325.
    139) Memphis Glove Company: Permeation Guide. Memphis Glove Company. Memphis, TN. 2001. Available from URL: http://www.memphisglove.com/permeation.html. As accessed 7/2/2001.
    140) Mendelson J, Wexler D, & Leiderman PH: A study of addiction to nonethyl alcohols and other poisonous compounds. Q J Stud Alcohol 1957; 18:561-580.
    141) Meng X, Paul S, & Federman DJ: Metabolic acidosis in a patient with isopropyl alcohol intoxication: a case report. Ann Intern Med 2015; 162(4):322-323.
    142) Monaghan MS, Olsen KM, & Ackerman BH: Measurement of serum isopropanol and the acetone metabolite by proton nuclear magnetic resonance: application to pharmacokinetic evaluation in simulated overdose model. J Toxicol Clin Toxicol 1995; 33:141-149.
    143) Montgomery Safety Products: Montgomery Safety Products Chemical Resistant Glove Guide, Montgomery Safety Products, Canton, OH, 1995.
    144) Mueller-Kronast N, Rabinstein AA, Voung L, et al: Isopropanol intoxication mimicking basilar artery thrombosis. Neurology 2003; 61:1456-1457.
    145) Mydler TT, Wasserman GS, & Watsin WA: Two-week-old infant with isopropanol intoxication. Pediatr Emerg Care 1993; 9:146-148.
    146) NFPA: Fire Protection Guide to Hazardous Materials, 11th ed, National Fire Protection Association, Quincy, MA, 1994.
    147) NFPA: Fire Protection Guide to Hazardous Materials, 13th ed., National Fire Protection Association, Quincy, MA, 2002.
    148) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 1, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2001.
    149) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 2, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2002.
    150) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 3, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2003.
    151) NRC: Acute Exposure Guideline Levels for Selected Airborne Chemicals - Volume 4, Subcommittee on Acute Exposure Guideline Levels, Committee on Toxicology, Board on Environmental Studies and Toxicology, Commission of Life Sciences, National Research Council. National Academy Press, Washington, DC, 2004.
    152) Nat-Wear: Protective Clothing, Hazards Chart. Nat-Wear. Miora, NY. 2001. Available from URL: http://www.natwear.com/hazchart1.htm. As accessed 7/12/2001.
    153) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2,3-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    154) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2,4-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    155) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2-Butylene Oxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648083cdbb&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    156) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,2-Dibromoethane (Proposed). United States Environmental Protection Agency. Washington, DC. 2007g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064802796db&disposition=attachment&contentType=pdf. As accessed 2010-08-18.
    157) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 1,3,5-Trimethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d68a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    158) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for 2-Ethylhexyl Chloroformate (Proposed). United States Environmental Protection Agency. Washington, DC. 2007b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648037904e&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    159) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Acrylonitrile (Proposed). United States Environmental Protection Agency. Washington, DC. 2007c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648028e6a3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    160) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Adamsite (Proposed). United States Environmental Protection Agency. Washington, DC. 2007h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    161) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Agent BZ (3-quinuclidinyl benzilate) (Proposed). United States Environmental Protection Agency. Washington, DC. 2007f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ad507&disposition=attachment&contentType=pdf. As accessed 2010-08-18.
    162) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Allyl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648039d9ee&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    163) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Aluminum Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    164) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Arsenic Trioxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2007m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480220305&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    165) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Automotive Gasoline Unleaded (Proposed). United States Environmental Protection Agency. Washington, DC. 2009a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cc17&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    166) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Biphenyl (Proposed). United States Environmental Protection Agency. Washington, DC. 2005j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064801ea1b7&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    167) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bis-Chloromethyl Ether (BCME) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006n. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648022db11&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    168) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Boron Tribromide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ae1d3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    169) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bromine Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2007d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648039732a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    170) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Bromoacetone (Proposed). United States Environmental Protection Agency. Washington, DC. 2008e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809187bf&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    171) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Calcium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    172) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Carbonyl Fluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803ae328&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    173) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Carbonyl Sulfide (Proposed). United States Environmental Protection Agency. Washington, DC. 2007e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648037ff26&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    174) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Chlorobenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2008c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064803a52bb&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    175) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Cyanogen (Proposed). United States Environmental Protection Agency. Washington, DC. 2008f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809187fe&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    176) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Dimethyl Phosphite (Proposed). United States Environmental Protection Agency. Washington, DC. 2009. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbf3&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    177) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Diphenylchloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    178) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648091884e&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    179) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyl Phosphorodichloridate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480920347&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    180) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethylbenzene (Proposed). United States Environmental Protection Agency. Washington, DC. 2008g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809203e7&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    181) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ethyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    182) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Germane (Proposed). United States Environmental Protection Agency. Washington, DC. 2008j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963906&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    183) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Hexafluoropropylene (Proposed). United States Environmental Protection Agency. Washington, DC. 2006. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064801ea1f5&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    184) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Ketene (Proposed). United States Environmental Protection Agency. Washington, DC. 2007. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ee7c&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    185) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Magnesium Aluminum Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    186) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Magnesium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    187) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Malathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2009k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064809639df&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    188) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Mercury Vapor (Proposed). United States Environmental Protection Agency. Washington, DC. 2009b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a8a087&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    189) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl Isothiocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963a03&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    190) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl Parathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2008l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963a57&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    191) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyl tertiary-butyl ether (Proposed). United States Environmental Protection Agency. Washington, DC. 2007a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064802a4985&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    192) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methylchlorosilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2005. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5f4&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    193) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    194) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Methyldichlorosilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2005a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c646&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    195) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN1 CAS Reg. No. 538-07-8) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006a. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    196) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN2 CAS Reg. No. 51-75-2) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006b. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    197) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Mustard (HN3 CAS Reg. No. 555-77-1) (Proposed). United States Environmental Protection Agency. Washington, DC. 2006c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6cb&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    198) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Tetroxide (Proposed). United States Environmental Protection Agency. Washington, DC. 2008n. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648091855b&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    199) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Nitrogen Trifluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009l. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963e0c&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    200) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Parathion (Proposed). United States Environmental Protection Agency. Washington, DC. 2008o. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480963e32&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    201) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Perchloryl Fluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e268&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    202) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Perfluoroisobutylene (Proposed). United States Environmental Protection Agency. Washington, DC. 2009d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e26a&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    203) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008p. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096dd58&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    204) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyl Mercaptan (Proposed). United States Environmental Protection Agency. Washington, DC. 2006d. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020cc0c&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    205) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phenyldichloroarsine (Proposed). United States Environmental Protection Agency. Washington, DC. 2007k. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020fd29&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    206) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phorate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008q. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096dcc8&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    207) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phosgene (Draft-Revised). United States Environmental Protection Agency. Washington, DC. 2009e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a8a08a&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    208) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Phosgene Oxime (Proposed). United States Environmental Protection Agency. Washington, DC. 2009f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e26d&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    209) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Potassium Cyanide (Proposed). United States Environmental Protection Agency. Washington, DC. 2009g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbb9&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    210) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Potassium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005c. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    211) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Propargyl Alcohol (Proposed). United States Environmental Protection Agency. Washington, DC. 2006e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec91&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    212) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Selenium Hexafluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2006f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec55&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    213) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Silane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006g. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d523&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    214) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sodium Cyanide (Proposed). United States Environmental Protection Agency. Washington, DC. 2009h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7cbb9&disposition=attachment&contentType=pdf. As accessed 2010-08-15.
    215) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sodium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    216) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Strontium Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005f. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    217) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Sulfuryl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2006h. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020ec7a&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    218) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tear Gas (Proposed). United States Environmental Protection Agency. Washington, DC. 2008s. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e551&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    219) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tellurium Hexafluoride (Proposed). United States Environmental Protection Agency. Washington, DC. 2009i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7e2a1&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    220) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tert-Octyl Mercaptan (Proposed). United States Environmental Protection Agency. Washington, DC. 2008r. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e5c7&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    221) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Tetramethoxysilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d632&disposition=attachment&contentType=pdf. As accessed 2010-08-17.
    222) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethoxysilane (Proposed). United States Environmental Protection Agency. Washington, DC. 2006i. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d632&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    223) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethyl Phosphite (Proposed). United States Environmental Protection Agency. Washington, DC. 2009j. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=0900006480a7d608&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    224) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Trimethylacetyl Chloride (Proposed). United States Environmental Protection Agency. Washington, DC. 2008t. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648096e5cc&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    225) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for Zinc Phosphide (Proposed). United States Environmental Protection Agency. Washington, DC. 2005e. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020c5ed&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    226) National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances: Acute Exposure Guideline Levels (AEGLs) for n-Butyl Isocyanate (Proposed). United States Environmental Protection Agency. Washington, DC. 2008m. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=09000064808f9591&disposition=attachment&contentType=pdf. As accessed 2010-08-12.
    227) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    228) National Institute for Occupational Safety and Health: NIOSH Pocket Guide to Chemical Hazards, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Cincinnati, OH, 2007.
    229) National Research Council : Acute exposure guideline levels for selected airborne chemicals, 5, National Academies Press, Washington, DC, 2007.
    230) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 6, National Academies Press, Washington, DC, 2008.
    231) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 7, National Academies Press, Washington, DC, 2009.
    232) National Research Council: Acute exposure guideline levels for selected airborne chemicals, 8, National Academies Press, Washington, DC, 2010.
    233) Natowicz M, Donahue J, & Gorman L: Pharmacokinetic analysis of a case of isopropanol intoxication. Clin Chem 1985; 31:326-328.
    234) Neese Industries, Inc.: Fabric Properties Rating Chart. Neese Industries, Inc.. Gonzales, LA. 2003. Available from URL: http://www.neeseind.com/new/TechGroup.asp?Group=Fabric+Properties&Family=Technical. As accessed 4/15/2003.
    235) Nelson BK, Brightwell WS, & MacKenzie-Taylor DR: Teratogenicity of n-propanol and isopropanol administered at high inhalation concentrations to rats. Food Chem Toxicol 1988; 26:247-254.
    236) North: Chemical Resistance Comparison Chart - Protective Footwear . North Safety. Cranston, RI. 2002. Available from URL: http://www.linkpath.com/index2gisufrm.php?t=N-USA1. As accessed April 30, 2004.
    237) North: eZ Guide Interactive Software. North Safety. Cranston, RI. 2002a. Available from URL: http://www.northsafety.com/feature1.htm. As accessed 8/31/2002.
    238) Ohashi Y, Nakai Y, & Ikeoka H: Acute effects of isopropyl alcohol exposure on the middle ear mucosa. J Appl Toxicol 1987; 7:205-211.
    239) Ohashi Y, Nakai Y, & Ikeoka H: An experimental study of respiratory toxicity of isopropyl alcohol. J Appl Toxicol 1988a; 8:67-71.
    240) Ohashi Y, Nakai Y, & Koshimo H: Toxicity of isopropyl alcohol exposure on the nasal mucociliary system in the guinea pig. Environ Res 1988b; 46:25-38.
    241) Osborn LM & Rosales TO: Corneal abrasion during alcohol sponging. Clin Pediatr (Phila) 1981a; 20(12):782.
    242) Osborn LM & Rosales TO: Corneal abrasion during alcohol sponging. Clin Pediatr 1981; 20:782.
    243) Pappas AA, Ackerman BH, & Olsen KM: Isopropanol ingestion: a report of six episodes with isopropanol and acetone serum concentration time data. Clin Toxicol 1991; 29:11-21.
    244) Parker KD, Fontan CR, & Yee JL: Gas chromatographic determination of ethyl alcohol in blood for mediolegal purposes. Anal Chem 1962; 34:1234.
    245) Parker KM & Lera TA: Acute isopropanol ingestion: pharmacokinetic parameters in the infant. Am J Emerg Med 1992; 10:542-544.
    246) Peberdy MA , Callaway CW , Neumar RW , et al: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care science. Part 9: post–cardiac arrest care. Circulation 2010; 122(18 Suppl 3):S768-S786.
    247) Plaa GL, Hewitt WR, & du Souich P: Isopropanol and acetone potentiation of carbon tetrachloride-induced hepatotoxicity: single versus repetive pretreatments in rats. J Toxicol Environ Health 1982; 9:235-250.
    248) Playtex: Fits Tough Jobs Like a Glove, Playtex, Westport, CT, 1995.
    249) Pohanish RP & Greene SA: Rapid Guide to Chemical Incompatibilities, Van Nostrand Reinhold, New York, NY, 1997.
    250) Pohanish RP: Sittig's Handbook of Toxic and Hazardous Chemicals and Carcinogens, 4th ed, Noyes Publications / William Andrew Publishing, Norwich, NY, 2002.
    251) Proctor NH, Hughes JP, & Fischman ML: Chemical Hazards of the Workplace, 2nd ed, JB Lippincott Co, Philadelphia, PA, 1989, pp 291-292.
    252) Product Information: dopamine hcl, 5% dextrose IV injection, dopamine hcl, 5% dextrose IV injection. Hospira,Inc, Lake Forest, IL, 2004.
    253) Product Information: norepinephrine bitartrate injection, norepinephrine bitartrate injection. Sicor Pharmaceuticals,Inc, Irvine, CA, 2005.
    254) RTECS: Registry of Toxic Effects of Chemical Substances.. National Institute for Occupational Safety and Health. Cincinnati, OH (Internet Version). Edition expires 2003; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    255) Rajabally YA & Mortimer NJ: Acute neuropathy and erythromelalgia following topical exposure to isopropanol. Vet Human Toxicol 2004; 46(1):24-25.
    256) Rich J, Scheife RT, & Katz N: Isopropyl alcohol intoxication. Arch Neurol 1990; 47:322-324.
    257) River City: Protective Wear Product Literature, River City, Memphis, TN, 1995.
    258) Rosansky SJ: Isopropyl alcohol poisoning treated with hemodialysis. Kinetics of isopropyl alcohol and acetone removal. J Toxicol Clin Toxicol 1982; 19:265-271.
    259) Rose DM, Muttray A, & Mayer-Popken O: Saliva as an alternate for blood to measure concentrations of acetone under exposure to isopropanol. Eur J Med Res 1999; 4(12):529-532.
    260) Safety 4: North Safety Products: Chemical Protection Guide. North Safety. Cranston, RI. 2002. Available from URL: http://www.safety4.com/guide/set_guide.htm. As accessed 8/14/2002.
    261) Sasaki MS & Matsubara S: J Radiat Res 1974; 15:47-48.
    262) Sax NI: Dangerous Properties of Industrial Materials, 6th ed, Van Nostrand Reinhold Company, New York, NY, 1984.
    263) Schick JB & Milstein JM: Burn hazard of isopropyl alcohol in the neonate. Pediatrics 1981; 68:587-588.
    264) Senz EH & Goldfarb DL: Coma in a child following use of isopropyl alcohol in sponging. J Pediatr 1958; 53:322-323.
    265) Servus: Norcross Safety Products, Servus Rubber, Servus, Rock Island, IL, 1995.
    266) Sheretz EF, Reed JW, & Zasnolli MD: Severe allergic keratoconjunctivitis and erythema multiforme after a routine eye examination: discerning the cause. Ann Ophthalmol 1991; 23:173-176.
    267) Sittig M: Handbook of Toxic and Hazardous Chemicals and Carcinogens, 3rd ed, Noyes Publications, Park Ridge, NJ, 1991.
    268) Standard Safety Equipment: Product Literature, Standard Safety Equipment, McHenry, IL, 1995.
    269) Stephan M, Gesell LB, & Snook CP: Pediatric isopropyl alcohol ingestion - not so bad (abstract). J Tox-Clin Tox 1997; 35:512-513.
    270) Stremski E & Hennes H: Accidental isopropanol ingestion in children. Pediatr Emerg Care 2000; 16:238-240.
    271) Teta MJ, Perlamn GD, & Ott MG: Mortality study of ethanol and isopropanol production workers at two facilities. Scan J Work Environ Health 1992; 18:90-96.
    272) Tingley: Chemical Degradation for Footwear and Clothing. Tingley. South Plainfield, NJ. 2002. Available from URL: http://www.tingleyrubber.com/tingley/Guide_ChemDeg.pdf. As accessed 10/16/2002.
    273) Trelleborg-Viking, Inc.: Chemical and Biological Tests (database). Trelleborg-Viking, Inc.. Portsmouth, NH. 2002. Available from URL: http://www.trelleborg.com/protective/. As accessed 10/18/2002.
    274) Trelleborg-Viking, Inc.: Trellchem Chemical Protective Suits, Interactive manual & Chemical Database. Trelleborg-Viking, Inc.. Portsmouth, NH. 2001.
    275) Trullas JC, Aguilo S, Castro P, et al: Life-threatening isopropyl alcohol intoxication: is hemodialysis really necessary. Vet Human Toxicol 2004; 46(5):282-284.
    276) Tyl RW, Masten LW, & Marr MC: Developmental toxicity evaluation of isopropanol by gavage in rats and rabbits. Fundam Appl Toxicol 1994; 22:139-151.
    277) U.S. Department of Energy, Office of Emergency Management: Protective Action Criteria (PAC) with AEGLs, ERPGs, & TEELs: Rev. 26 for chemicals of concern. U.S. Department of Energy, Office of Emergency Management. Washington, DC. 2010. Available from URL: http://www.hss.doe.gov/HealthSafety/WSHP/Chem_Safety/teel.html. As accessed 2011-06-27.
    278) U.S. Department of Health and Human Services, Public Health Service, National Toxicology Project : 11th Report on Carcinogens. U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. Washington, DC. 2005. Available from URL: http://ntp.niehs.nih.gov/INDEXA5E1.HTM?objectid=32BA9724-F1F6-975E-7FCE50709CB4C932. As accessed 2011-06-27.
    279) U.S. Environmental Protection Agency: Discarded commercial chemical products, off-specification species, container residues, and spill residues thereof. Environmental Protection Agency's (EPA) Resource Conservation and Recovery Act (RCRA); List of hazardous substances and reportable quantities 2010b; 40CFR(261.33, e-f):77-.
    280) U.S. Environmental Protection Agency: Integrated Risk Information System (IRIS). U.S. Environmental Protection Agency. Washington, DC. 2011. Available from URL: http://cfpub.epa.gov/ncea/iris/index.cfm?fuseaction=iris.showSubstanceList&list_type=date. As accessed 2011-06-21.
    281) U.S. Environmental Protection Agency: List of Radionuclides. U.S. Environmental Protection Agency. Washington, DC. 2010a. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-sec302-4.pdf. As accessed 2011-06-17.
    282) U.S. Environmental Protection Agency: List of hazardous substances and reportable quantities. U.S. Environmental Protection Agency. Washington, DC. 2010. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-sec302-4.pdf. As accessed 2011-06-17.
    283) U.S. Environmental Protection Agency: The list of extremely hazardous substances and their threshold planning quantities (CAS Number Order). U.S. Environmental Protection Agency. Washington, DC. 2010c. Available from URL: http://www.gpo.gov/fdsys/pkg/CFR-2010-title40-vol27/pdf/CFR-2010-title40-vol27-part355.pdf. As accessed 2011-06-17.
    284) U.S. Occupational Safety and Health Administration: Part 1910 - Occupational safety and health standards (continued) Occupational Safety, and Health Administration's (OSHA) list of highly hazardous chemicals, toxics and reactives. Subpart Z - toxic and hazardous substances. CFR 2010 2010; Vol6(SEC1910):7-.
    285) U.S. Occupational Safety, and Health Administration (OSHA): Process safety management of highly hazardous chemicals. 29 CFR 2010 2010; 29(1910.119):348-.
    286) United States Environmental Protection Agency Office of Pollution Prevention and Toxics: Acute Exposure Guideline Levels (AEGLs) for Vinyl Acetate (Proposed). United States Environmental Protection Agency. Washington, DC. 2006. Available from URL: http://www.regulations.gov/search/Regs/contentStreamer?objectId=090000648020d6af&disposition=attachment&contentType=pdf. As accessed 2010-08-16.
    287) Urben PG: Bretherick's Handbook of Reactive Chemical Hazards, Volume 1 and 2, 5th ed, Butterworth-Heinemann Ltd, Oxford, England, 1995.
    288) Vasiliades J, Pollock J, & Robinson CA: Pitfalls of the alcohol dehydrogenase procedure for the emergency assay of alcohol. A case study of isopropyl overdose. Clin Chem 1978; 24:383-385.
    289) Verschueren K: Handbook of Environmental Data on Organic Chemicals, 2nd Ed, Van Nostrand Reinhold Company, New York, NY, 1983.
    290) Verschueren K: Handbook of Environmental Data on Organic Chemicals, 3rd Ed, Van Nostrand Reinhold Company, New York, NY, 1997.
    291) Vicas IMO & Beck R: Fatal inhalational isopropyl alcohol poisoning in a neonate. Clin Toxicol 1993; 31:473-481.
    292) Visudhiphan P & Kaufman H: Increased cerebrospinal fluid protein following isopropyl alcohol intoxication. State J Med 1971; 71:887-888.
    293) Vivier PM, Lewander WJ, & Martin HF: Isopropyl alcohol intoxication in a neonate through chronic dermal exposure: a complication of a culturally-based umbilical care practice. Pediatr Emer Care 1994; 10:91-93.
    294) Vujasinovic M, Kocar M, Kramer K, et al: Poisoning with 1-propanol and 2-propanol. Hum Exp Toxicol 2007; 26(12):975-978.
    295) Wallgren H: Relative intoxicating effects in rats of ethyl, propyl and butyl alcohols. ACTA Pharmacol Toxicol 1960; 16:217-222.
    296) Watkins AM & Keogh EJ: Alcohol burns in the neonate. J Paediatr Child Health 1992; 28:306-308.
    297) Weil CS, Smyth HF, & Nale TW: Quest for a suspected industrial carcinogen. Arch Ind Hyg Occup Med 1952; 5:535-547.
    298) Wells Lamont Industrial: Chemical Resistant Glove Application Chart. Wells Lamont Industrial. Morton Grove, IL. 2002. Available from URL: http://www.wellslamontindustry.com. As accessed 10/31/2002.
    299) Wise IR: Alcohol sponge baths (Letter). N Engl J Med 1969; 280:840.
    300) Wittmann S, Gilig T, & Dietz HG: Isopropanol and acetone level in serum after preoperative surface disinfection with antiseptics conatining isopropanol. Blutalkohol 1992; 28:306-308.
    301) Workrite: Chemical Splash Protection Garments, Technical Data and Application Guide, W.L. Gore Material Chemical Resistance Guide, Workrite, Oxnard, CA, 1997.
    302) Wrenn K: Isopropyl alcohol intoxication (Editorial). Arch Neurol 1991; 48:18.
    303) Zahlsen K, Aarstad K, & Nilsen OG: Increased microsomal metabolism of n-hexane in rat kidney and liver after inhalation of isopropanol. Arch Toxicol Suppl 1984; 7:268-271.
    304) Zaman F, Pervez A, & Abreo K: Isopropyl alcohol intoxication: a diagnostic challenge. Am J Kidney Dis 2002; 40:E12.
    305) Zaman F, Pervez A, & Abreo K: Isopropyl alcohol intoxication: a diagnostic challenge. Am J Kidney Dis 2002a; 40(3):E12.